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ABSTRACT
REDOX SIGNALING IN THE ZEBRAFISH EMBRYO AND IMPLICATIONS FOR
ENDOCRINE PANCREAS MORPHOGENESIS
May 2020
ARCHIT RASTOGI, B.TECH., VIT UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Alicia R. Timme-Laragy
The glutathione (GSH) system evolved to combat oxygen toxicity in nearly all living
organisms, and serves as the predominant cellular redox buffer in vertebrates. This
dissertation explores the roles of GSH during embryogenesis using the zebrafish
(Danio rerio). The first agnostic in vivo characterization of GSH utilization in the
embryo revealed strict spatiotemporal GSH profiles in developing organ systems.
Interruption of these GSH profiles by exogenous xenobiotics led to organ specific
adverse developmental outcomes; pancreatic β-cells were found to be especially
susceptible and developed atypical morphologies following redox active xenobiotic
exposures. Pancreatic β-cells lacked expression of Nrf2a (Nuclear factor erythroid
(2) like 2; Nrf2a – zebrafish Nrf2 co-ortholog), a transcription factor that regulates
many antioxidant genes. Using a novel application of BioGEE (biotinylated
glutathione ethyl ester) to visualize in situ protein glutathionylation at the whole
organism level, experiments demonstrated the lack of Nrf2 expression was
accompanied by oxidized GSH pools. Moreover, altered Nrf2a signaling and
differential protein glutathionylation patterns were found to underlie aberrant
pancreatic β-cell morphologies. Using the techniques developed here, the mode of
action of PFOS, a ubiquitous environmental toxicant known to disrupt β-cell
vi

morphogenesis, was interrogated. PFOS disrupted GSH profiles in the developing
pancreas and yolk, and, induced Nrf2a expression in the endocrine pancreas, where
it is normally absent. Notably, bolstering cellular GSH pools rescued these changes,
indicating PFOS toxicity in the pancreas is redox mediated. Experiments done in cell
culture to better resolve the mechanism were inconclusive, and merit further
investigation. This dissertation demonstrates that organ systems develop in specific
redox microenvironments, and consequently, have separate resilience to toxicant
mediated redox perturbations that change with developmental stage. Further,
embryonic pancreatic β-cells have oxidized GSH redox conditions, and many
xenobiotics disrupt redox signaling in these cells potentially altering their reserve
antioxidant capacity and rendering them vulnerable to later life exposures. Given
the multitude of exogenous xenobiotics people are exposed to everyday, this work
has broad implications for identifying exposed populations and their underlying
susceptibility to metabolic disorders. Although these exposures are impossible to
avoid, by identifying vulnerable populations, lifestyle interventions can be
implemented, minimizing the risk of disease outcomes.
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CHAPTER 1
INTRODUCTION
Sections Reprinted (adapted) with permission from:
Timme-Laragy AR, Hahn ME, Hansen JM, Rastogi A, Roy MA. Redox stress and
signaling during vertebrate embryonic development: Regulation and responses.
Semin Cell Dev Biol. 2018 Aug;80:17-28. doi: 10.1016/j.semcdb.2017.09.019. Epub
2017 Sep 22. PMID: 28927759; PMCID: PMC5650060. Copyright 2017 Elsevier Ltd.

1.1 Oxygen and Life
Oxygen and reactive oxygen species play fundamental direct and indirect
roles in biology. Many transcriptional and translational changes occur as a direct
result of cellular oxygen concentrations. Yet, life did not evolve with oxygen on the
planet; oxygenation of the atmosphere occurred only about 2.4 billion years ago –
whereas life evolved on Earth 4 billion years ago [1]. This imparts a duality to
oxygen – it is both essential to life and toxic to life, an idea succinctly stated as “the
oxygen paradox” [2]. To protect against the toxic effects of oxygen while capitalizing
on its biological potential, life forms have evolved various redox defenses.

1.1.1 Glutathione
A few well-characterized redox couples include thioredoxin, cysteine,
Nicotinamide Adenine Dinucleotide (NAD+/NADH), Flavin Adenine Dinucleotide
(FAD+/FADH) and glutathione. Of these couples, the glutathione redox couple

1

predominates with reduced glutathione occurring in mammalian cells in the mM
range. Reduced glutathione (GSH) can neutralize reactive oxygen species by serving
as an electron donor and forming a disulfide bond either with itself or other
biomolecules; many of these reactions are catalyzed by a Glutathione-s-transferase
(GST). Oxidized glutathione (GSSG), a homodimer of GSH can be recycled back to its
reduced form in a reaction catalyzed by glutathione reductase (GR) (Fig. 1.1). The
GSH and GSSG concentrations can then be incorporated into the Nernst equation to
arrive at the cellular redox potential (GSH Eh), expressed in mV [3-5].
GSH can also be conjugated to cysteine residues on proteins via a Sglutathionylation post-translational modification in a reaction catalyzed by the
Glutathione-S-transferase (GST) enzyme superfamily. This reversible protein
modification leads to conformational changes in protein molecules that often
underlie disease conditions. For instance, the highly pleiotropic NF- κB transcription
factor is a sensitive target of glutathionylation. Glutathionylation of the Cys62
residue in the DNA Binding Domain of NF- κB is sufficient to block its DNA binding
activity. Glutathionylation of the Cys179 residue of the inhibitory κB kinase causes a
conformational change, rendering it inactivated [6, 7]. p53 is another example of a
well-characterized glutathionylation target. The Cys124, 141 and 182 residues are
glutathionylated during malignancies [8-10]. It is important to note here, that these
modifications are reversible, thereby providing the cell with a useful control over
proteome function. Disease states arise when glutathionylation occurs at a higher
than normal rate, usually as a result of disrupted GSH homeostasis, and
consequently, the cellular redox potential.
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1.1.2 Glutathione during Embryogenesis
The cellular redox potential is especially important during embryogenesis, a
time of heightened cell division and differentiation. The redox environment of the
developing embryo is highly dynamic, yet tightly regulated. Reactive oxygen species
(ROS) serve as key signals in multiple signaling cascade pathways, with important
ramifications for cell fate decisions[11, 12]. In addition to ROS directly acting as
signaling species, the overall redox potential of the embryo is critical to normal
embryonic development. The redox potential of the embryo changes in very specific
directions at specific times, ensuring correct development [13]. Disruptions in the
redox potential can lead to early differentiation, altered cell migration patterns,
apoptosis and changes in embryo polarity [14-16].
The cellular redox potential can be disrupted by both endogenous and
exogenous factors. Endogenous factors are typically ROS generated as a byproduct
of metabolic reactions. Environmental toxicants are common exogenous disruptors
of the cellular redox potential [17]. This disruption can be a direct result of GSH
depletion as part of the Phase II metabolism of these xenobiotics; alternately, they
can undergo a reduction to generate a product that can react with oxygen to
regenerate the parent compound, thereby entering a redox cycle. These reactions
consume cellular reducing agents like NADH and produce large amounts of ROS like
the superoxide radical, hydroxyl radical, and, hydrogen peroxide as byproducts [18].
This can shift the cellular redox potential from being reducing to more oxidizing,
leading to potentially deleterious consequences for the developing embryo

3

depending upon the time of exposure, given the tightly controlled nature of redox
potential changes during embryogenesis.
In zebrafish embryos, the redox potential changes very specifically and
directionally during development, in a pattern similar to that seen in developing
mouse embryos. Embryos are increasingly resistant to oxidizing exposures from 18
hours post fertilization (hpf) (when the majority of the endoderm derived organs
start developing) -72 hpf (most major organs, with the exception of the liver, have
developed and the embryo hatches); after hatching, embryos become much more
sensitive to pro-oxidant exposures [19]. This is in keeping with changes in the
concentration of GSH in zebrafish embryos during development, which nearly
doubles between 24 to 36 hpf [20]. Similar changes have been reported in cultured
mouse embryos, with disruptions of the GSH Eh leading to increased protein
glutathionylation, especially of proteins involved in the spliceosome and in glucose
metabolism [21]. GSH synthesis has also been demonstrated to be essential for
mammalian embryonic development, with mouse embryos lacking a functional
enzyme to synthesize GSH failing to gastrulate and aborting before reaching the 812 somite stage [22, 23].

1.1.3 Glutathione and Nrf2
During development, the cellular response to ROS depends on existing redox
homeostasis and antioxidant defenses. GSH Eh affects signaling pathways via
modification of protein sulfhydryls, akin to phosphorylation in controlling protein
function [24, 25]. Following oxidative stress, upregulation of antioxidant defenses
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(including GSH) can occur. GSH synthesis, along with a majority of antioxidant
defense genes are under the control of the transcription factor Nuclear Factor
Erythroid 2-like 2 (NFE2L2 or Nrf2) [26]. Nrf2, a basic leucine zipper transcription
factor, is ubiquitously expressed and constitutively bound to its cytosolic repressor,
a dimer of Kelch like ECH-associated protein 1 (Keap1) [27-29]. Upon redox
disruptions, Keap1 undergoes a conformational change, disrupting Nrf2
ubiquitination (Fig. 1.2). This allows Nrf2 to stabilize and translocate to the nucleus
where it binds to the Antioxidant Response Element (ARE), thereby maintaining
redox homeostasis [30-32]. In addition to redox homeostasis, Nrf2 plays important
roles in diverse processes like inflammation, DNA repair, lipid metabolism and
Phase II detoxification reactions [33-35].
Important roles for Nrf2 have also been demonstrated during
embryogenesis. In mice, Nrf2 knockout embryos developed significantly higher
neural damage following postnatal exposure to valproic acid, a redox active
antiepileptic [36]. Prenatal exposure to methamphetamine also caused significantly
higher incidences of fetal resorption, lower fetal birth weight, and abnormal
olfactory bulb development in Nrf2 knockout mice compared to controls [37].
Constitutive activation of Nrf2 also results in postnatal lethality in mice, indicating
the importance of normal Nrf2 signaling during development [38]. In the zebrafish
embryo, knockdown of the Nrf2a protein (zebrafish co-ortholog of human Nrf2)
temporally oxidizes the GSH Eh, indicating a role for Nrf2a in maintaining embryonic
redox homeostasis [19].
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1.2 The DoHAD Paradigm
Developmental xenobiotic exposures to agents like alcohol and tobacco
smoke that manifest as overt diseased states upon birth are well-characterized.
More recently, there is an increasing awareness of xenobiotic exposures that result
in subtle changes predisposing individuals to adverse health outcomes later in life.
Stated as the Developmental Origins of Health and Disease (DoHAD) hypothesis,
multiple explanations like metabolic reprogramming, epigenetic reprogramming
and subtle structural defects have been proposed as underlying mechanisms [3941]. The countless xenobiotics an organism is exposed to daily coupled with the
insidious nature of the DoHAD paradigm, underscores the need to better
characterize these subtle changes.
Disrupted embryonic redox homeostasis is a potential mechanism that could
lead to later life adverse health impacts. Disrupted redox homeostasis has indeed
been identified as the mechanism of action for certain well-known teratogens.
Thalidomide, a antiemetic pregnancy drug that led to gross morpholical deformities
in offspring, is known to disrupt nuclear binding of NF- κB due to oxidative stress.
This leads to decreased transcription and translation of FGF10, resulting in limb
malformations [42, 43]. The developmental toxicity of alcohol is also known to arise
due to oxidative stress, ROS produced as a byproduct of alcohol detoxification
impact neurogenesis, DNA repair and other transcriptional changes [44, 45].
Besides specific disruptions in transcriptional and translational responses,
the embryonic redox homeostasis is also important for cell fate decisions. Small
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shifts in ROS levels that do not induce gross toxicity, cause different effects in
different cell types. For instance, a 15% increase in the concentration of ROS is
sufficient to induce higher differentiation of human embryonic stem cells; the
response of human embryonic stem cells differs considerably from that of somatic
cells upon oxidizing insults [46, 47]. ROS caused a JNK mediated reduction in the
phosphorylation levels of p38MAPK and AKT pathways, thereby inactivating them
in human embryonic stem cells [46, 47]. The ramifications of altered differentiation
patterns on organogenesis and structural changes are easy to imagine.
The divergent redox resilience of stem cells and somatic cells likely arises
from different levels of GSH in the different cell types. Actively differentiating cells
are known to have a different redox profile from proliferative cells [48, 49]. To
facilitate proper redox signaling during development and function, certain cell types
often have lowered redox defenses, potentially making them more vulnerable to
developmental disruptions of redox homeostasis. Here, we expand on redox
signaling in the pancreas.

1.2.1 Redox Signaling in Developing Pancreatic Beta Cells
Pancreas development is regulated by a variety of molecular signals [50-52]. One
redox-sensitive transcription factor essential for pancreas development is pancreatic and
duodenal homeobox 1 (Pdx1), which signals differentiation of pancreatic precursor cells,
distinguishing them from endoderm cells in the developing gut. Pdx1 becomes
progressively restricted to beta cells where it regulates the promoter activity of
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preproinsulin [53]. Pdx1 is essential to the maintenance of beta cell function and
survival, with ablation of Pdx1 signaling leading to pancreatic agenesis [54].
The activity of Pdx1 is sensitive to redox signaling. During hyperglycemia, as
blood glucose and ROS climb, the DNA binding activity of Pdx1 decreases; this activity
is restored with antioxidant treatments such as NAC [55, 56]. Kaneto et al [55] further
showed that increased ROS in rat islets caused activation of the c-Jun N-terminal kinase
(JNK) pathway, leading to a marked reduction of insulin production, and blocking the
JNK pathway had a cytoprotective effect on beta cells experiencing oxidative stress.
Developmental exposure to ROS has also been shown to affect beta cell growth in
vivo. We recently demonstrated a reduction in beta cell mass and a shortened pancreas
phenotype in the zebrafish embryo after developmental exposure to the pro-oxidant tert
butyl hydroperoxide [57]. H2O2, has been shown to specifically activate the ERK-1/ERK2 pathway in the developing pancreas and initiate beta cell differentiation [58].
Additional support for the importance of H2O2 redox signaling can be found in a study by
Rovira et al, [59], in which treatment of zebrafish embryos with the pharmaceuticals
disulfiram and methiopropamine resulted in disrupted proliferation and premature
differentiation of pancreatic beta cells, and thus smaller islets. These pharmaceuticals
inhibited the conversion of retinaldehyde to retinoic acid; retinoic acid can ablate H2O2
mediated cell signaling in embryonic stem cells. Another study found that
undernourished rat fetuses had small islets with high levels of activated ERK-1/ERK-2,
further implicating ROS in beta cell development [60]. While a shift towards oxidative
conditions in the beta cell can interfere with development and function of these cells, a
reduction or loss of redox signaling due to inappropriate reductive redox conditions is
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similarly detrimental. For example, exposure to high concentrations of NAC during
pancreatic development in rats reduced the number of pancreatic progenitor cells; this
finding persisted into adulthood, as rats exposed to NAC in utero had a 2.5- fold decrease
in the number of beta cells [58].

1.2.2 Redox Signaling Modulates Beta Cell Function
Modulation of antioxidant and cytoprotective gene expression has also been
shown to affect the function of beta cells. Mitochondrial ROS triggers glucose-stimulated
insulin secretion [61]; conversely, an increase in cellular antioxidant defenses is
associated with impaired insulin secretion [61, 62]. However, understanding the role of
redox signaling in beta cell function is quite complicated, with numerous contradictory
findings. Some studies report that low levels of oxidative stress are required to stimulate
insulin production [63-66]. Nrf2 null mice have lower serum insulin and elevated blood
glucose [67], while Keap1 knockdown mice that constitutively activate Nrf2 on the
Leptin-deficient background (ob/ob) have increased antioxidants but exacerbated
systemic insulin resistance [68]. Others have demonstrated loss of Nrf2 in beta cells
aggravates diabetes, while repeated Nrf2 activation attenuates diabetes [69, 70]. In a
hypomorphic Keap1 knockdown model, constitutive activation of Nrf2 had a
cytoprotective effect on pancreatic beta cells, making them more resistant to oxidative
stress [70]. In addition, when Keap1 hypomorphs were crossed with a diabetic mouse
model strain (db/db), islets with activated Nrf2 were highly responsive to glucose and the
diabetic phenotype in the db/db mice was rescued [70]. The Keap1-knockdown mice also
were protected against induction of diabetes and obesity by a high-calorie diet [70]. There
are many factors that may explain these contradictory studies including differences in
9

timing, genetic background, endogenous antioxidant defenses, duration and repetition of
the oxidative challenge, among others. Additional studies are required to fully understand
the role of ROS in beta cell function, and whether there are any inherent differences
between developing beta cells and those found in the mature adult.

1.2.3 Pancreatic Susceptibility to Developmental Xenobiotic Exposures
Xenobiotic exposures during development to redox active chemicals have
been shown to impact pancreatic β-cell development in the zebrafish model.
Exposure to perfluorooctanesulfonic acid (PFOS), a recalcitrant environmental
toxicant disrupts pancreatic islet development, with Nrf2a activation exacerbating
PFOS toxicity [71, 72]. Exposures to mono-(2-ethyl-hexyl)phthalate (MEHP),
butylparaben and Polychlorinated Biphenyl 126 (PCB126) also disrupt β-cell
development, with GSH Eh and Nrf2a implicated in all cases [73-75]. However, these
studies have investigated redox changes at an organismic level. Specific GSH and
Nrf2a changes within the pancreas remain unexplored.
1.3 Hypothesis and Rationale
This dissertation aims to better characterize the spatiotemporal changes in
GSH levels during vertebrate embryonic development, and, how embryos combat
toxicant induced disruptions of this highly sensitive redox potential at this
vulnerable stage. The central hypothesis is that GSH changes during
embryogenesis aberrantly induce Nrf2 leading to adverse developmental
outcomes in an organ specific fashion.
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During embryogenesis, the GSH Eh changes in a specific, directional manner
with these changes demarcating important developmental events [13, 76-78]. Given
the diverse population of cells that makes up the embryo, it is easy to hypothesize
divergent GSH levels. Chapter 2 tests this hypothesis using monochlorobimane, a
GSH specific dye. The in situ visualization of GSH dynamics in live embryos allows
for the delineation of temporal windows of redox sensitivity, along with underlying
susceptibilities of organ systems to redox changes. This system could also be applied
to understand the contribution of the GSH system to the toxicities of various
compounds, providing a data point to construct adverse outcome pathways.
To test the ramifications of GSH interruptions, Chapter 3 tests for the
aberrant expression of Nrf2 using immunohistochemistry. Nrf2, a pleiotropic
transcription factor, is a meaningful target given its central role in regulation of
cellular redox homeostasis. Nrf2 activation is known to increase cellular GSH pools,
altering the GSH Eh [79, 80]. Given the sensitivity of developing cells to redox shifts,
it is easy to imagine the potential adverse outcomes of aberrant Nrf2 activation
during embryogenesis. In addition to Nrf2 expression patterns, Chapter 3
investigates the downstream effects of this aberrant activation in the form of
protein glutathionylation. Protein glutathionylation is an important, understudied
posttranslational modification that can activate or inactivate the functional domains
of proteins.
Chapters 2 and 3 utilize zebrafish embryos as a model system. Zebrafish
embryos are transparent, with rapid exogenous development and conserved redox
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biology, serving as an excellent model system. They allow for the investigation of
GSH and Nrf2 levels at a whole organism level.
To investigate redox homeostatic mechanisms at a more fundamental level,
Chapter 4 utilizes mammalian cell culture systems. GSH levels and Nrf2 activation
are studies in cell lineages chosen based on the results of Chapters 2 and 3. This
allows for a direct comparison of the inherent redox sensitivities of different organ
lineages to different toxicants.
The larger goal of this project is to better characterize the changes in the GSH
redox potential during embryonic development, and, lay a mechanistic foundation
for better understanding how embryos combat these changes at this vulnerable
stage. Moreover, it will further the understanding of how diseases arising later in
life due to developmental disruptions of this sensitive redox potential.
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Figure 1.1The glutathione cycle and modulating factors. The glutathione cycle.
Grey italicized text represents names of enzymes involved in the pathway. All the
treatments done are highlighted in red.
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Figure 1.2: The Nrf2 pathway. Nrf2a is the zebrafish co-orthologue of human Nrf2.
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CHAPTER 2

MAPPING GLUTATHIONE UTILIZATION IN THE DEVELOPING ZEBRAFISH
(DANIO RERIO) EMBRYO

Reprinted (adapted) with permission from:
Rastogi A, Clark CW, Conlin SM, Brown SE, Timme-Laragy AR. Mapping glutathione
utilization in the developing zebrafish (Danio rerio) embryo. Redox Biol. 2019
Sep;26:101235. doi: 10.1016/j.redox.2019.101235. Epub 20x19 Jun 5. PMID:
31202080; PMCID: PMC6581987. Copyright 2019 Elsevier B.V.

2.1 Abstract
Glutathione (GSH), the most abundant vertebrate endogenous redox buffer,
plays key roles in organogenesis and embryonic development, however, organspecific GSH utilization during development remains understudied.
Monochlorobimane (MCB), a dye conjugated with GSH by glutathione-s-transferase
(GST) to form a fluorescent adduct, was used to visualize organ-specific GSH
utilization in live developing zebrafish (Danio rerio) embryos. Embryos were
incubated in 20 μM MCB for 1 hour and imaged on an epifluorescence microscope.
GSH conjugation with MCB was high during early organogenesis, decreasing as
embryos aged. The heart had fluorescence 21-fold above autofluorescence at 24 hpf,
dropping to 8.5-fold by 48 hpf; this increased again by 72 hpf to 23.5-fold, and
stayed high till 96 hpf (18-fold). The brain had lower fluorescence (10-fold) at 24
15

and 48 hpf, steadily increasing to 30-fold by 96 hpf. The sensitivity and specificity of
MCB staining was then tested with known GSH modulators. A 10-minute treatment
at 48 hpf with 750 μM tert-butylhydroperoxide, caused organ-specific reductions in
staining, with the heart losing 30% fluorescence, and, the brain ventricle losing 47%
fluorescence. A 24 hour treatment from 24-48 hpf with 100 μM of N-Acetylcysteine
(NAC) resulted in significantly increased fluorescence, with the brain ventricle and
heart showing 312% and 240% increases respectively, these were abolished upon
co-treatment with 5 μM BSO, an inhibitor of the enzyme that utilizes NAC to
synthesize GSH. A 60 minute 100 μM treatment with ethacrynic acid, a specific GST
inhibitor, caused 30% reduction in fluorescence across all measured structures.
MCB staining was then applied to test for GSH disruptions caused by the toxicants
perfluorooctanesulfonic acid and mono-(2-ethyl-hexyl)phthalate; MCB fluorescence
responded in a dose, structure and age-dependent manner. MCB staining is a robust,
sensitive method to detect spatiotemporal changes in GSH utilization, and, can be
applied to identify sensitive target tissues of toxicants.

2.2 Introduction
Endogenous redox signaling has important ramifications for cell fate decisions
and organogenesis during embryonic development, with precise regulatory
mechanisms having evolved to permit redox signaling pathways to proceed; a loss of
control over these pathways results in oxidative stress [11, 58, 81-83]. The most
abundant endogenous redox buffer in vertebrates is the small thiol, glutathione – a
tripeptide of glutamate, cysteine and glycine. Reduced glutathione (GSH) can
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neutralize redox disruptors by serving as an electron donor and forming a disulfide
bond either with itself, or, with other molecules. Oxidized glutathione (GSSG), a
homodimer of GSH can be recycled back to its reduced form in a reaction catalyzed
by glutathione reductase (GR) [3, 4, 84]. The ratio of oxidized to reduced glutathione
concentrations ([GSSG]/[GSH]) can be incorporated into the Nernst equation to
arrive at the cellular redox potential (Eh), reported in mV [5]. The GSH Eh of the
developing embryo is highly dynamic, yet tightly regulated, with interruptions
leading to early differentiation, altered cell migration patterns, apoptosis and
changes in embryo polarity [14-16].
Relatively small changes in the GSH Eh can have significant biological
consequences. For example, a 12 to 16 mV oxidation of the total cellular GSH pool is
sufficient to increase GST activity 2-3 fold, resulting in increased differentiation of
human adenocarcinoma cells into enterocytes [85]. In general, the GSH Eh becomes
increasingly oxidized as cells grow and differentiate. CaCo-2 cells show a 40 mV
oxidation in the GSH Eh as they approach contact inhibition; this change is restricted
to the GSH redox couple, with no observable change in the thioredoxin system –
another key vertebrate redox buffer [86]. Typically, the GSH/GSSH couple Eh ranges
from -260 to -150 mV in living systems, with disruptions in the Eh impacting signal
transduction, protein function, and cell cycle regulation [5, 87].
Many environmental toxicants are potent exogenous disruptors of the GSH Eh
[17]. This disruption can be a direct result of GSH depletion as part of the Phase II
metabolism of these xenobiotics; alternately, these chemicals can undergo a
reduction to generate a product that can react with oxygen to regenerate the parent

17

compound, thereby entering a redox cycle. These reactions consume cellular
reducing agents like NADPH and produce large amounts of reactive oxygen species
(ROS) as byproducts, shifting the GSH Eh from being largely reducing to more
oxidizing [18]. Xenobiotics can also activate the Nuclear Factor Erythroid-2 (Nrf2)
transcription factor, which coordinates cellular antioxidant defense machinery [72,
88-91]. This can be through direct interactions with Nrf2, or, due to changes in the
GSH Eh. Nrf2 translocates to the nucleus and activates the transcription of the Nrf2
gene battery, which include GSH synthesis genes, and, the Glutathione-S-Transferase
(GST) enzyme superfamily [30]. GSTs conjugate GSH to xenobiotics; these GSconjugates can often be readily excreted, providing living systems with an efficient
method to combat toxic insults. GST expression however, is highly spatiotemporally
divergent in vertebrates, leading to differential susceptibilities and sensitivities of
organ systems during development [92-95]. Furthermore, disruptions in the GSH Eh
during organogenesis cause altered glutathionylation of spliceosome related
proteins leading to dysregulation of normal signaling in rat fetuses; these alterations
occur to different degrees in different embryonic compartments, underscoring the
need to better characterize spatiotemporal glutathione redox dynamics during
embryogenesis [21].
Zebrafish are a widely used model for embryonic development, owing to
their low cost, external development, transparent embryos, high fecundity and
accelerated growth when contrasted with conventional mammalian models [96, 97].
The zebrafish model is also finding broad application in the field of developmental
toxicology, with a steady increase in the number of studies utilizing zebrafish for the
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risk and safety assessment of chemical exposures [98, 99]. In zebrafish embryos, the
GSH Eh changes specifically and directionally during development, in a pattern
similar to that seen in developing mouse embryos [13, 20].
The ability of the GSH system to respond and recover from oxidizing
conditions changes with developmental stage. Zebrafish embryos are increasingly
resistant to oxidizing exposures from 18 hours post fertilization (hpf) (when the
majority of the endoderm derived organs start developing) -72 hpf (most major
endoderm-derived organs have developed and the embryo hatches); after hatching,
embryos become much more sensitive to pro-oxidant exposures [19]. This is in
keeping with changes in the concentration of GSH in zebrafish embryos during
development, which nearly doubles between 24 to 36 hpf [20]. A similar trajectory
for the GSH Eh has been reported in cultured mouse embryos [21]. GSH synthesis
has also been demonstrated to be essential for mammalian embryonic development,
with mouse embryos lacking a functional enzyme to synthesize GSH failing to
gastrulate and aborting before reaching the 8-12 somite stage [22, 23].
Although total GSH concentrations and overall GSH Eh during early
embryogenesis are well reported, data regarding the spatial distribution of GSH
during embryonic development are limited. This is a critical gap in knowledge, since
different organs develop in their own redox microenvironment, and hypothetically,
are differentially affected by the aforementioned redox disruptions. This gap has
arisen, in part, due to few suitable methods for the visualization of GSH redox
dynamics in live animals. The use of genetically encoded fluorescent redox sensors,
especially roGFP to monitor physiological GSH Eh has been steadily increasing [100].
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In the zebrafish, roGFP has been used to monitor the effects of biliary toxins on the
GSH concentration of the developing liver, and, GSH Eh responses of developing
cardiomyocytes and enterocytes to prooxidant challenges [101, 102]. Although
these transgenic models provide a useful tool to test a priori hypotheses regarding
the organ-specific toxicity of xenobiotics, there is a need for unbiased, whole
organism-level data about GSH redox dynamics, particularly in the context of the
identifying sensitive target organs in developmental toxicity studies. Fluorescent
dyes are amongst the most feasible options to measure redox dynamics at a wholeorganism level. These primarily include dyes that label ROS like dichlorofluorescein
diacetate (DCF-DA), or, dyes that label GSH like halogenated bimanes [103, 104].
Monochlorobimane (MCB), a cell-permeable non fluorescent bimane dye, is
conjugated to GSH by GST forming a fluorescent adduct in living systems [105].
Thus, fluorescence intensity of MCB serves as a good proxy for the rate of
glutathione utilization [104]. Historically, MCB has been used predominantly in cell
culture studies to determine glutathione compartmentalization and changes
associated with diverse processes including but not limited to cell growth,
differentiation, xenobiotic metabolism and, oocyte maturation [106-108]. Previous
studies have compared various small thiol dyes and found that MCB displays greater
specificity for GSH than other thiol dyes [109, 110]. In the zebrafish, the Gst isozyme
superfamily has been well-characterized both during development and in adult fish
[92]. MCB is known to be a substrate for all the known zebrafish GST isozymes, with
Gstτ1a having the lowest affinity and Gstp1 having the highest affinity [111].
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In this study, we investigate the suitability in vivo staining of zebrafish
embryos with MCB to visualize tissue-specific glutathione utilization. We confirm
the specificity and sensitivity of MCB as a reliable tool to measure changes in
glutathione utilization using well-characterized modulators of the glutathione
pathway in a live animal (Fig. 1.1). Finally, we applied this method to detect spatial
changes in GSH homeostasis upon exposure to the environmental contaminants
perfluorooctanesulfonic acid (PFOS) and mono(2-ethylhexyl) phthalate (MEHP), as
an illustration of its application potential.

2.3 Material and methods

2.3.1 Chemicals and Reagents
Monochlorobimane (Catalog #M13813MP) was purchased from Molecular
Probes (Eugene, OR, USA). Dimethyl Sulfoxide (DMSO; Catalog #BP231-1) was
purchased from Fisher Scientific (Pittsburgh, PA, USA). Tert-Butyl hydroperoxide
(tBOOH; Catalog #A13926AP) and N-acetyl-L-cysteine (NAC; Catalog #A1540914)
were purchased from Alfa Aesar (Ward Hill, MA, USA). Ethacrynic Acid (ETA;
Catalog #BMLEI1280001) and L-Buthionine-(S,R)-sulfoximine (BSO; Catalog #BMLFR117-0500) were purchased from Enzo Life Sciences (Farmingdale, NY, USA).
Potassium perfluorooctane sulfonate (PFOS; Catalog #33829) was purchased from
Millipore-Sigma (Burlington, MA, USA). Mono(2-ethylhexyl) phthalate (MEHP;
Catalog #ALR-138S-CN) was purchased from AccuStandard (New Haven, CT, USA).

21

2.3.2 Fish Husbandry and Embryo Sampling
Homozygous mitfa(b692/b692) mutant zebrafish (Danio rerio) crossed on the AB
wild type strain were used for all experiments. This line was chosen as these
mutants fail to develop melanocytes and display an albinism phenotype thereby
eliminating pigment that would otherwise occlude imaging. Adult fish were
maintained on an automated Aquaneering (San Diego, CA, USA) system in
accordance with the Guide for the Care and the Use of Laboratory Animals of the
National Institutes of Health and with approval from the University of
Massachusetts Amherst Institutional Animal Care and Use Committee (Animal
Welfare Assurance Number A3551-01). The fish were housed at 28.5 °C on a 14h
light, 10h dark cycle in, and fed GEMMA Micro 300 (Skretting, Westbrook, ME, USA)
twice daily. Large breeding tanks were setup with approximately 20 adult female
and 10 adult male fish. Embryos were collected 1h post fertilization, washed and
screened for fertilization status and staged according to Kimmel et al. [112]. The
embryos were dechorionated at 24 hpf and reared in borosilicate glass scintillation
vials with 1 ml 0.3x Danieau’s per embryo.

2.3.3 Glutathione Modulating Exposures
Embryos aged 48 hpf were exposed to 750 µM tBOOH, stock prepared in
water, for 10 or 30 minutes, the tBOOH was washed out immediately prior to MCB
staining. Embryos were exposed to either 100 µM NAC, 5 µM BSO, or, a combination
of the two from 24 to 48 hpf. These concentrations were chosen based on previous
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studies in zebrafish embryos [113, 114]. The NAC and BSO stocks were prepared in
0.3x Danieau’s. The embryos were MCB stained and imaged at 48 hpf. Embryos aged
48 hpf were exposed to 100 µM ETA (0.1% DMSO) for 30 minutes or 1 hour
immediately prior to MCB staining and imaging. Embryos aged 48 hpf were exposed
to 10 µM Menadione (0.01% DMSO) for 1 hour immediately prior to MCB staining
and imaging. All embryos were manually dechorionated at 24 hpf using fine
watchmaker’s forceps and reared, exposed and stained in 20 ml borosilicate glass
scintillation vials with 1 ml 0.3x Danieau’s per embryo.

2.3.4 Toxicant Exposures
Embryos were exposed to 3.2 µM or 32 µM PFOS (0.01% DMSO),or, 200 µg/L
MEHP (0.01% DMSO) starting at 3 hpf. The PFOS and MEHP concentrations were
chosen based on previous studies which established that these doses produce sublethal effects in zebrafish embryos, with no gross malformations [71, 72, 74, 115].
The dosing solutions were refreshed daily; embryos were manually dechorionated
at 24 hpf and reared, exposed and stained in 20 ml borosilicate glass scintillation
vials with 1 ml 0.3x Danieau’s per embryo. The embryos were imaged at 48 hpf and
72 hpf, with exposures terminated immediately prior to MCB staining and imaging.

2.3.5 Monochlorobimane Staining, Imaging and Data Analysis
Pools of ten dechorionated embryos were placed in 3 ml 0.3x Danieau’s in
glass scintillation vials and stained with 200 µM MCB (final DMSO conc. 0.1%) for 1
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hour. The embryos were then immobilized on ice for two minutes, washed with
fresh Danieau’s for two minutes and imaged using an inverted fluorescence
microscope (EVOS FL Auto, Life Technologies, Pittsburgh, PA, USA) equipped with a
DAPI filter set. In our hands, anaesthetizing embryos with MS-222 produced
inconsistent, irreproducible staining patterns. This could be due to MS-222’s action
on Ca2+ release channels, and, the many interactions between Ca2+ and the GSH
system [116]. Embryos were mounted in drops of 3% methylcellulose on glass
slides and oriented laterally; we found that MCB stained plastic dishes and pipettes,
causing increased levels of background fluorescence. To account for the inverted
microscopy, all images presented here are mirror flipped to represent the actual
orientation of the embryos. Heat-maps were generated using the 16Colors LUT in
ImageJ. All image analysis was done using the EVOS FL Auto software. Briefly,
freehand outlines of the specific structures were traced, and, their mean
fluorescence intensity recorded, all images were blinded before analysis. All images
were corrected for background and auto fluorescence.

2.3.6 Statistical Analysis
All experiments were carried out to conform to OECD guidelines, with a
minimum of two independent experimental repeats [117]. A one-way ANOVA
followed by a Tukey-Kramer post-hoc test with a confidence interval of 95% was
used to determine statistically significant differences between treatment groups and
structures; the statistical software JMP Pro 13 was used for all analyses. We
attributed the slight differences staining in control embryos to inter-clutch
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variability. To better control for this, a DMSO treated or untreated control group
was used in every single experimental repeat; all structures were normalized to the
mean yolk fluorescence of this group within each experimental repeat before the
data were combined for statistical analyses.

2.4 Results

2.4.1 Glutathione utilization is highly spatiotemporal in the developing
zebrafish embryo
To determine the suitability of in vivo MCB staining to identify
spatiotemporal changes in GSH utilization in the developing embryo, zebrafish
embryos were stained with MCB for 1 hour and imaged at 24, 48, 72 and 96 hpf.
These timepoints were chosen because they correspond to organogenesis,
pharyngulation, hatching and larval stages; they have also been identified as
important timepoints for investigating developmental toxicity in the zebrafish
model by the OECD [117]. By 96 hpf most organs have developed and the
eleutheroembryos are free-swimming; zebrafish embryos exhaust their yolk and
start feeding at 7 dpf, and, are considered larvae at this age.
Fluorescence patterns in embryonic structures differed significantly at each
timepoint (Fig. 2.1), with the gut, heart and brain demonstrating the highest
fluorescence. Of the structures measured, the heart and the brain had the most
dynamic fluorescence patterns. The heart had a fluorescence that was 21-fold above
autofluorescence (p<0.0001) at 24 hpf, dropping to 8.5-fold by 48 hpf (p<0.0001);
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the fluorescence increased again by 72 hpf to 23.5-fold (p<0.0001), and stayed high
till 96 hpf (18-fold; p). The values are expressed as fold autofluorescence to account
for the inherently high autofluorescence seen in certain structures in the zebrafish
embryo (Fig. 2.9). The brain had lower fluorescence (10-fold, p<0.0001) at 24 and
48 hpf, this steadily increased, doubling to 20-fold (p<0.0001) at 72 hpf and
increasing to 30-fold (p<0.0001) at 96 hpf. The other structures measured showed
higher fluorescence levels of 10-fold (p<0.0001) at 24 hpf, with these levels
decreasing as the embryos got older. Raw fluorescence values are tabulated in Table
1.1 (Table 1.1).

2.4.2 MCB conjugation is glutathione-s-transferase mediated in live,
developing zebrafish embryos
To determine that MCB conjugation was Gst mediated in zebrafish embryos,
and consequently, representative of the glutathione utilization, we treated 48 hpf
embryos with 100 µM ethacrynic acid (ETA) for 30 minutes or 1 hour prior to MCB
staining and imaging. ETA is a specific Gstp inhibitor; Gstp is the predominant
isozyme in zebrafish at these early embryonic stages, with two paralogs Gstp1 &
Gstp2 [92, 111]. A 30-minute treatment with ETA was insufficient to cause any
significant changes in glutathione utilization across all measured structures (Fig.
2.10); however a 1 hour ETA treatment caused a significant decrease compared to
DMSO controls of approximately 30% (p<0.0001) in MCB fluorescence in all
structures measured, with exception of the brain ventricle and the 12th somite
which did not change (Fig. 2.2); the 12th somite was chosen as being representative
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of the muscular tissue. An important thing to note here is that these control
embryos were treated with 0.1% DMSO, which caused a significant decrease in
glutathione utilization as compared to untreated embryos and embryos treated with
0.01% DMSO (Fig. 2.11). Owing to ETA’s inherent physical properties and low
solubility in DMSO, we were unable to lower the final DMSO concentration below
0.1% in these experiments.

2.4.3 Monochlorobimane responds robustly to GSH modulation in the
zebrafish embryo
In order to establish the sensitivity of MCB to changes in glutathione
concentration, we employed the glutathione modulators NAC and BSO. NAC readily
enters living cells and is deacetylated by cellular esterases thereby generating
cysteine, the rate-limiting constituent of glutathione. BSO is an irreversible inhibitor
of γ-glutamylcysteine synthetase, the enzyme that catalyzes the conjugation of
cysteine and glutamate to generate γ-glutamylcysteine, a precursor of glutathione
(Fig. 2.3). We treated zebrafish embryos for 24 hours with either 100 µM NAC, 5 µM
BSO, or, a combination of the two from 24 to 48 hpf, followed by MCB staining and
imaging. 100 µM NAC significantly increased fluorescence levels across all the
structures measured when compared to controls, with the greatest increases
observed in the brain ventricle (312%; p<0.0001) and the heart (240%; p<0.0001)
and the lowest increase in the yolk (52%; p<0.0001). We chose to measure MCB
fluorescence in the brain ventricle instead of the brain, due to the difficulty in
distinguishing brain tissue from ventricular tissue at these earlier developmental
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timepoints when observed laterally [118]. Furthermore, the ventricular system is
full of cerebrospinal fluid and provides the brain with all its nutrients and growth
factors, along with GSH, thereby serving as a good proxy for redox changes in the
brain [119]. In the zebrafish, the blood-brain barrier develops and matures only
between 3 to 10 days post fertilization, and thus, compartmentalization effects were
not an immediate concern for our experiments [120].
A co-treatment with 5 µM BSO abolished NAC-induced increases almost
completely with all the structures showing only about a 15% increase, and the yolk
showing a 6% decrease as compared to the control embryos, however, these were
not significantly different from the untreated controls (Fig. 2.3). These data indicate
a preference for glutathione as the primary thiol substrate for MCB in zebrafish
embryos, as opposed to NAC. Exposure to 5 µM BSO by itself was unable to induce
any statistically significant differences in fluorescence across the structures
measured, but, the values showed a trend towards increased fluorescence. These
data are consistent with prior studies in zebrafish embryos showing that a 24 hour
pretreatment with BSO is insufficient to cause glutathione depletion [114]. This
could possibly be due to increased Gst expression levels following a BSO exposure.
Raw fluorescence intensity values are provided in Table 1.2 (Table 1.2).

2.4.4 Differential GSH depletion in the zebrafish embryo evokes
commensurate responses in MCB fluorescence
We next tested the robustness of MCB staining to glutathione depletion
utilizing two glutathione depleting agents – tBOOH and menadione. We treated 48
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hpf zebrafish embryos with 750 µM tBOOH for 10-minutes or 30-minutes
immediately prior to MCB staining. Following an acute, sub-lethal 10-minute
exposure to 750 µM tBOOH, zebrafish embryos showed a significant reduction in
MCB fluorescence across all the structures measured (Fig 5). Of the structures
measured, the heart had the smallest decrease with only a 28% (p=0.001) reduction
and the brain ventricle had the greatest decrease with 47% (p<0.0001) reduction in
fluorescence when compared to untreated control embryos. Following a longer 30minute exposure to 750 µM tBOOH, the embryos started to return to near
homeostatic conditions. All the structures measured showed an increase in MCB
fluorescence. The yolk showed the greatest increase in fluorescence, gaining 45%
(p<0.0001) fluorescence followed by the brain ventricle, which gained 38%
(p=0.0028) fluorescence when compared to the 10-minute exposure group. The
heart, which showed the least loss of fluorescence following a 10-minute exposure,
also showed the smallest increase in fluorescence increasing by only 14%. All the
structures returned to within 20% of their fluorescence when compared to the
untreated condition.
We treated 48 hpf zebrafish embryos with 10 µM menadione for 1 hour
immediately prior to MCB staining and imaging. A significant decrease was
measured across all structures measured; however, the fluorescence of the embryo
overall did not show a significant change (Fig. 2.5). The brain ventricle showed the
greatest reduction in fluorescence, losing around 46% (p<0.0001) fluorescence, all
the other structures showed a drop of around 30% (p<0.0001) when compared to
DMSO controls. Notably, this was different from embryos treated with tBOOH, which
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saw a slightly more pronounced drop in fluorescence across all structures following
a 10 minute exposure; the embryos were however able to recover fluorescence
following a longer, 1 hour exposure. This was in stark contrast with embryos
exposed to menadione, which showed a decrease in MCB fluorescence following a 1
hour exposure. This is consistent with the different mechanisms of GSH depletion
employed by the two compounds: tBOOH depletes GSH by utilizing it as an electron
donor during its reduction, whereas menadione directly conjugates GSH and also
enters a redox cycle which continuously generates ROS leading to even greater
consumption of GSH. MCB fluorescence patterns confirm this, tBOOH caused a
sharp, but short-lived decrease in MCB fluorescence, whereas menadione caused a
sustained decrease in MCB fluorescence.

2.4.5 PFOS and MEHP cause dose-specific, spatiotemporal changes in GSH
utilization
In order to assess the potential of MCB as a method for detecting tissuespecific changes in GSH utilization and thus potential target organs in zebrafish
embryos, we used the environmental toxicants PFOS and MEHP; we have previously
characterized the effects of these chemicals on the GSH Eh in zebrafish embryos [72,
74]. Embryos were exposed to either 3.2 or 32 µM PFOS from 3 hpf until either 48
or 72 hpf. At these timepoints, the embryos were stained with MCB and imaged. We
saw both dose and age specific effects of PFOS exposure. At 48 hpf, a 3.2 µM
exposure resulted in a significant increase of about 80% (p<0.0001) fluorescence
nearly across all structures when compared to control embryos, with the exception
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of the yolk, which only showed a 28% (p<0.0001) increase. The increased
fluorescence persisted at 72 hpf, with embryos showing greater nearly 150%
(p<0.0001) increase across all structures except the yolk and the gut, which showed
only a 50% (p<0.0001) increase in fluorescence (Fig. 2.6). In stark contrast to this,
the 32 µM dose induced a decrease in fluorescence across all the structures
measured, with the most drastic decrease in the yolk and gut showing a 45%
(p<0.0001) and 60% (p<0.0001) decrease respectively at both 48 and 72 hpf, with
no overtly discernible phenotypic abnormalities (Fig. 2.6). These responses mirror
our previous U-shaped dose response curve findings in zebrafish embryos [71, 72].
Following an exposure paradigm similar to PFOS, we exposed zebrafish embryos
to 200 µg/L MEHP from 3 hpf until either 48 or 72 hpf. At these timepoints, the
embryos were stained with MCB and imaged. We found greater a disruption in GSH
homeostasis in 48 hpf embryos, with these effects lessening by 72 hpf. At 48 hpf, the
embryos showed significantly decreased MCB fluorescence; 42% (p<0.0001) in the
myotome tissue, 15% (p<0.002) in the heart, and, 21% (p<0.0001) in the brain
ventricle (Fig. 2.7). These structures maintained significantly decreased
fluorescence until 72 hpf, however, the fluorescence started trending towards
homeostasis, with the myotome tissue showing a decrease of 24% (p<0.0001) and
the heart showing a decrease of 12% (p<0.0001). MCB fluorescence in the brain
ventricle remained low, displaying a 24% (p<0.0001) decrease (Fig. 2.7). At 72 hpf,
the gut showed an 18% increase in fluorescence, however, this was not statistically
significant due to high variability; this variability was due to significant interindividual differences in the autofluorescence values of the gut (Supp. Fig S4).
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2.5 Discussion
In this study, we present MCB staining of live zebrafish embryos as a technique to
monitor glutathione redox dynamics during vertebrate embryonic development. We
validated the responsiveness of MCB using well-characterized GSH modulators, and
found it to be suitably sensitive to detect changes in GSH localization in vivo. During
development, GSH utilization hotspots correlated closely with regions of high
differentiation; these hotspots were differentially affected by GSH modulation. Some
organs like the heart and brain displayed a greater resiliency against GSH depletion,
while the gut was especially vulnerable to GSH modulation. When applied to test the
effects of PFOS exposure on embryonic GSH homeostasis, MCB was able to discern
bidirectional changes in GSH utilization effected by different doses of PFOS at distinct
developmental timepoints, corroborating experimentally determined GSH concentrations
and the GSH Eh in the zebrafish embryo [72].

2.5.1 Changes in GSH utilization correspond to key developmental events
The Gst superfamily enzymes primarily function as detoxification enzymes,
and are highly evolutionarily conserved [93, 121]. In the zebrafish, Gst enzymes
follow expression patterns similar to those seen in humans; this is true at both
transcriptomic and proteomic levels [92, 111, 122, 123]. MCB fluorescence patterns
during embryonic development mirror Gst expression and embryonic GSH levels,
and, correlate with key developmental events. At 24 hpf, during early
organogenesis, the fluorescence levels across all structures measured were high,
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with the heart showing the highest fluorescence (Fig. 2.1). The zebrafish heart is the
first mesoderm-derived organ to form, it starts differentiating and is a linear cardiac
tube at 24 hpf; by 48 hpf the heart has formed the atrium and ventricle, and, heart
differentiation is complete by 72 hpf [124, 125]. The heart displayed its lowest
fluorescence at 48 hpf, we also saw a decrease in fluorescence across all structures
measured at this developmental timepoint (Fig. 2.1). Of the timepoints we studied,
48 hpf is known to have the most oxidized GSH Eh, and, it is also when many of the
Gst isozyme expression levels are at their lowest [20, 92].
The heart and brain displayed significantly higher fluorescence levels at later
timepoints, with the brain displaying the highest fluorescence at 96 hpf (Fig. 2.1). Of
the 17 characterized zebrafish Gst isoforms the zebrafish brain predominantly
expresses Gstµ1 and 2, Gstp2 and Gsto1 [92]. With the exception of Gsto1, all these
isoforms are known to be highly expressed during zebrafish embryonic
development at both the protein [92] and the mRNA level [20, 122, 123]. Gstµ1 and
2 and Gstp1 and 2 especially show significantly increased protein expression levels
at 72 and 96 hpf, likely causing the sustained fluorescence increase in the brain [92].
Worth noting here – the heart, brain and brainstem of a 13 week old human fetus
have also been reported to have high levels of cytosolic GSH, and, high Gstp1 and
Gstµ1 activities [126]. While it is difficult to make a direct comparison, at 13 weeks,
most of the endoderm derived organs have patterned and differentiated,
approximately corresponding to 96 hpf zebrafish embryos.
The zebrafish liver bud is formed around 48 hpf, with the liver lobes growing
completely by 120 hpf [127, 128]. The zebrafish liver, being the primary site of
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Phase II metabolism, has a very high expression of all the Gst isoforms [92].
Additionally, the liver is also a major site of glutathione biosynthesis, and, is
reported to have high levels of GSH in adult zebrafish [20, 92]. Unsurprisingly, we
found high MCB fluorescence in the developing liver at both 72 and 96 hpf, the only
organs with higher levels of fluorescence were the heart and brain (Fig. 2.1). These
data reflect reported GSH levels in human embryos and fetuses [126]. The
consonance of our results with reported GSH measures across multiple vertebrate
embryos (Fig. 2.8) confirm the high degree of evolutionary conservation of the GSH
system in zebrafish, and, indicate the suitability of MCB staining to study GSH redox
dynamics in zebrafish embryos [13, 20, 126, 129-131].

2.5.2 GSH modulation elicits divergent responses in different organ systems
during vertebrate organogenesis
The glutathione pathway has been well-studied, with the rate-limiting steps
and many small-molecule inhibitors & activators well-characterized (Fig. 1.1) [4].
MCB shows a robust response to modulation of the GSH pathway in zebrafish
embryos. For instance, 48 hpf zebrafish embryos exposed to 750 µM tBOOH showed
a reduction in MCB fluorescence following a 10 minute exposure, but returned to
near homeostatic conditions following a longer, 30 minute exposure. These data
were concordant with previous glutathione measures done using reverse-phase
HPLC, where we found that 48 hpf embryos experienced a decrease in GSH and an
increase in GSSG 10-minutes post exposure with the embryos returning to nearly
homeostatic conditions after about 60 minutes [19]. This likely occurs due to the
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way living systems combat peroxide ROS, and, the short biological half-life of tBOOH
[132]. Peroxides can directly oxidize sulfhydryl groups in biomolecules, however,
they are quickly decomposed by cellular catalases. Given that following our tBOOH
treatments, the embryos were stained for 1 hour with MCB in the absence of the
peroxide, the higher MCB fluorescence is potentially reflective of the ability of the
embryos to buffer against, and, recover following a brief short-lived pro-oxidant
insult. The additional 20 minutes prior to MCB exposure may have provided the
embryos ample time to completely neutralize cellular tBOOH levels, and, allowed for
the GSH system to start recovering. The fluorescence patterns in the gut support this
interpretation, as the gut, a site of very high Gst expression does not recover as well
as some of the other structures which have lower Gst expression levels.
In contrast menadione, a quinone that depletes reduced glutathione directly
by conjugating GSH, and indirectly by producing ROS, caused a decrease in MCB
fluorescence across the entire embryo [133, 134]. While the % change is significant,
this decrease is especially apparent when comparing the heatmaps of DMSO treated
embryos with menadione treated embryos (Fig. 2.4). We observed near complete
ablation of fluorescence intensity in most embryonic structures upon menadione
treatment. Previously, an exposure to 10 µM menadione has been reported to
significantly increase ROS levels in developing zebrafish embryos, with
perturbations in endogenous ROS levels persisting at least 24 hours after the
menadione exposure is terminated [135].
Ethacrynic acid (ETA), a specific inhibitor of the Gst isozyme family, caused a
more subtle reduction in fluorescence when compared to tBOOH and menadione,
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which directly deplete cellular levels of GSH (Figs. 4 & 5) [136-138]. ETA is known
to be a highly effective inhibitor of multiple zebrafish Gst isozymes, with the
greatest reduction of Gstp activity [111]. The gut, a site of high GSH utilization and
Gst expression, was especially sensitive to an ETA exposure, showing the greatest
decrease in MCB fluorescence (Fig. 2.2). This is consistent with what is known about
Gst expression profiles in zebrafish embryos; Gstp and Gstµ are the most highly
expressed isozymes at the 48 hpf timepoint, with the intestine being the highest site
of expression for these isozymes within the animal [92]. Confirming previous
findings, our data indicate the GSH specificity of MCB, and, suggest that MCB
fluorescence is a valid biological reflection of changes in GSH concentration and the
rate of GSH utilization in zebrafish embryos.
In literature, MCB has been reported to react with small molecular thiols
other than GSH, though this arises from the divergent substrate preferences of the
Gst family present in different species [139-141]. Given the high affinity for MCB
observed for the zebrafish Gst isozyme family, and the overabundance of GSH in the
cellular pool of reduced thiols, this was not an immediate concern for our
experiments [111]. The specificity of MCB for GSH as opposed to other thiols in
zebrafish is further evidenced by the fact that exposure to BSO along with NAC
completely abolished the increases in fluorescence seen when the embryos were
exposed to NAC alone (Fig. 2.5). Since NAC boosts the cellular GSH pool and BSO
inhibits the synthesis of de novo GSH synthesis, if the increase in MCB fluorescence
upon exposure to NAC was merely due to MCB binding to NAC, the co-exposure with
BSO would have failed to eliminate these gains. Collectively, the robust response of
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MCB to glutathione modulation in zebrafish embryos points to its suitability as a
method for detecting perturbations of the GSH homeostasis during embryonic
development in this model system.

2.5.3 Monochlorobimane provides a powerful tool to observe organism level
glutathione redox dynamics
Existing literature has established that the developing vertebrate embryo uses
highly specific glutathione redox signaling for spatiotemporal control and
organogenesis [11, 13, 20, 21]. Utilizing reverse-phase HPLC, accurate measures of
glutathione concentrations in living systems have further bolstered the hypothesis
that disruptions of the glutathione potential during development can lead to adverse
health outcomes later in life [42, 90, 95, 142, 143]. Due to its inherent nature, HPLC
requires samples to be suspended in a solvent, making it impossible to glean any
spatial information regarding organism level glutathione dynamics in a live embryo.
MCB has previously been employed to visualize changes in glutathione utilization in
early mouse embryos, however, these experiments had to be terminated well before
organogenesis began [144]. By using MCB in zebrafish embryos, we were able to
reliably measure changes in glutathione utilization in situ, in vivo with little to no
disruptions of normal embryogenetic processes like organogenesis.
Given the highly specific changes seen in MCB fluorescence patterns in different
organs during development (Fig. 2.1), the application of MCB to identify target
tissues of toxicants becomes readily apparent. To illustrate this, we exposed
zebrafish embryos to PFOS and MEHP, known exogenous GSH Eh disruptors. A 200
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µg/L MEHP exposure caused a reduction in MCB fluorescence in all structures
measured except the yolk and gut, at both 48 hpf and 96 hpf. The decrease in
fluorescence was greater at 48 hpf than at 72 hpf, with the exception of the brain
ventricle, which demonstrated a sustained decrease (Fig. 2.7). These data are
consistent with prior studies that found MEHP induces ROS and disrupts GSH
homeostasis [74, 145, 146].
The gut showed an interesting trend, with no observable change at 48 hpf, but,
an 18% increase fluorescence at 72 hpf (Fig. 2.7). However, this was found to be
statistically insignificant due to high inter-individual variability. This variability was
caused, in part, due to inconsistent autofluorescence patterns in the gut at 72 hpf,
despite all the embryos being matched for age (Fig. 2.12). A possible reason for
these inherent differences could be the development of the gut microbiome, which
is known to be present and highly variable by this stage in zebrafish embryos [147,
148].
The trend towards recovery as the embryos age is likely reflective of the changes
in GSH related gene expression induced by MEHP; Glutathione-disulfide reductase
(Gsr), the enzyme that recycles GSSG to GSH is known to be significantly
upregulated by MEHP at 72 hpf, while Gstp expression is downregulated [74].
Furthermore, the overall GSH Eh of embryos exposed to MEHP was found to be
uninterrupted by MEHP at 96 hpf [74]. Thus, one possible interpretation of these
data is that MEHP induces structure-specific redox disruptions that biological
antioxidant defenses are able to overcome given time. This also provides an example
of the need for tools to better interrogate GSH redox dynamics during different
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stages of embryonic development; given the highly specific GSH Eh patterns during
embryogenesis, it is not hard to imagine that a disruption of redox homeostasis
during critical developmental events may make an individual more susceptible to
disease later in life.
We found that the developing gut and yolk, sites of high glutathione utilization,
showed a reduction in fluorescence upon treatment with 32 µM PFOS. (Fig. 2.6).
Previously, we have shown that exposure to 32 µM PFOS leads to a more oxidized
glutathione pool in zebrafish embryos, with increased GSSG concentrations; we also
found reduced expression of Keap1a and Keap1b, cytosolic repressors of Nrf2 [72].
We observed accelerated yolk consumption, and, aberrant pancreatic development
upon PFOS exposure [71, 72].
Worth noting here is that the lower dose of PFOS induced an increase in MCB
fluorescence, resulting in a non-monotonic inverted “U-shaped” dose response
curve. This trend has been observed previously with PFOS, and is likely owing to an
adaptive response in embryos at the lower dose. [71, 72]. We found that a 3.2 µM
PFOS exposure resulted in the brain ventricle gaining the greatest MCB fluorescence
at both 48 hpf (72%) and 72 hpf (158%; Fig. 2.6), however, this was not
accompanied by any adverse phenotypic outcomes. In the zebrafish model, a chronic
larval 0.5 µM exposure to PFOS has been reported to induce later-life behavioral
effects in exposed fish, and, morphological abnormalities in their offspring [149].
Furthermore, a single static exposure to 2 µM PFOS during early development (3 hpf
to 120 hpf) has been reported to cause behavioral changes that persist well into
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adulthood, despite no apparent morphological defects; tgfb1a expression was found
to be significantly upregulated in animals exposed to 2 µM PFOS [150].
The Tgfb1 pathway and the Keap1-Nrf2 pathway have been well-studied to
identify potential crosstalk, with divergent effects seen in different cell lineages. In
renal cells, overexpression of Tgfb1 has been shown to induce ROS formation, and,
decrease the expression of Nrf2 and GSH synthesis genes, leading to malignant
transformation; in human pancreatic ductal cells, Tgb1 was found to activate Nrf2
and GSH synthesis genes, leading to malignant transformation [151, 152]. Tgfb1 is a
good representative example of a transcription factor affected by disrupted GSH
homeostasis, and, these data indicate the predictive power of MCB as a technique to
identify potential PFOS target organs.
The increases in MCB could arise due to increases in GSH concentrations, or,
increases in GST activity. While the determination of the exact molecular
mechanisms underlying PFOS toxicity, as they relate to GSH homeostasis, is outside
the scope of this study, MCB could be employed in conjunction with ETA to tease
apart changes in GSH concentration vs GST activity. Additionally, GSH modulators
like NAC and BSO could be employed to better understand the contribution of GSH
perturbations to PFOS toxicity. Thus, experiments with MCB could serve as an initial
screening tool, helping discern embryonic structures adversely affected by
xenobiotics; further studies could then be carried out to pinpoint exact molecular
targets mediating xenobiotic toxicity.
While MCB cannot easily differentiate between changes in GSH concentration vs
GSH utilization, it does provide an indiscriminate, unbiased method to investigate

40

the differential sensitivity of organs to xenobiotic induced GSH disruptions;
furthermore, it presents organ specific GSH disruptions in the context of the entire
organism, as opposed to genetically encoded fluorescent redox biosensors like Grx1roGFP2 and the RedoxFluor that look at GSH changes in a specific organ structure
Eh .
A key shortcoming of MCB staining is the inability to directly translate
fluorescence levels to GSH concentrations or the GSH Eh. However, this could be
overcome by coupling MCB staining with redox biosensors, which can equilibrate
with the intracellular pools of GSH and give a more precise quantitative estimate of
the GSH Eh[153, 154]. Furthermore, MCB is susceptible to some of the same
challenges as other chemical GSH probes [155]. It is capable of binding to other
biological thiols, albeit with less specificity than its specificity for GSH; the
responsiveness of MCB is also greatly impacted by the inherent GSH concentrations
and Gst expression profiles of the cell type being investigated.
Both the intracellular GSH concentrations and Gst expression profiles are known
to be highly divergent across different organs, and, organisms. For instance, MCB is
known to be a poor substrate for a majority of primate GST isozymes [141].
Therefore, it is necessary to characterize these factors in any model system before
the application of MCB as a GSH detection tool. In the zebrafish, GSH levels are
known to be in the mM range, higher than other thiols like cysteine, and, the Gst
isozymes are known to utilize MCB efficiently, hence, it is well-suited for this
technique [20, 111]. Caution must be exercised when translating changes in MCB
fluorescence to biological outcomes. Unlike more advanced imaging techniques like
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MALDI imaging of GSH, MCB is incapable of distinguishing between GSH and GSH
conjugates derived in a thiol independent manner. MCB’s utility derives from its
ability to be quickly and inexpensively employed to screen perturbations in the GSH
system across a whole embryo upon xenobiotic exposure.
The developing embryo is a highly organized collection of diverse populations of
cells & biological matrices, all of which have divergent redox potentials [48]. This,
coupled with the ever increasing number of environmental toxicants underscore the
need for techniques to accurately, affordably and quickly assess interruptions in the
redox microenvironment during development with minimal disruptions to normal
biology. MCB staining could help bridge a gap in developmental redox biology by
facilitating visualization of tissue specific changes in GSH during normal embryonic
development. By enabling us to observe organism level changes in glutathione redox
dynamics upon chemical exposure, it can find broad application as a tool to gauge
the safety of chemicals.

2.6 Conclusions
This study presents a novel application of MCB as a tool to visualize glutathione
redox dynamics in vivo during vertebrate embryonic development using the
zebrafish model. GSH localization was found to be highly spatiotemporal in the
developing embryo, corresponding to Gst expression patterns. MCB responded
robustly to GSH modulation, with different organs displaying different sensitivities
to GSH modulation. The heart and brain were found to be especially resilient to
oxidizing redox disruptions. The highly specific and reproducible spatiotemporal
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patterns of GSH utilization are indicative of there being potential biological
consequences of developmental GSH disruptions. The environmental toxicants PFOS
and MEHP, exogenous disruptors of the GSH Eh, induced dose-dependent, age and
structure specific changes in MCB fluorescence. Our data indicate the broad
application potential of MCB as an unbiased method to assess GSH interruptions
arising from chemical exposures in live embryos.
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Figure 2.1: Glutathione utilization is highly spatiotemporal during embryonic
development. Zebrafish embryos aged 24 (n=16), 48 (n=27), 72 (n=29) and 96
(n=27) hpf were stained with MCB and imaged. Values are mean+SEM fluorescence
intensities normalized to the autofluorescence intensity of the specified structure in
unstained embryos. Different letters indicate statistically significant differences
(p≤0.05), as determined by a one-way ANOVA followed by a Tukey-Kramer posthoc. Right: Heatmaps of MCB fluorescence at the specified ages. For raw,
unprocessed images and autofluorescence images, please refer to Fig. 2.9.
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Figure 2.2: GST inhibition elicits a reduction in MCB fluorescence. Zebrafish
embryos aged 48 hpf were exposed to 100 µM Ethacrynic Acid for 1 hour (n=21
fish) immediately prior to MCB staining and imaging. The fluorescence intensity
was compared to 0.1% DMSO treated controls (n=24 fish). Values are mean + SEM
fluorescence intensities normalized to the mean fluorescence intensity of yolk of
untreated controls, combined from at least 2 independent experimental runs. Stars
indicate statistically significant differences (p≤0.05), as determined by a t-test
across the indicated structure. Right: Heatmaps of MCB fluorescence observed in
embryos exposed to the stated treatment.
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Figure 2.3: GSH modulation elicits a robust MCB response. Zebrafish embryos
aged 48 hpf were exposed to 100 µM N-AcetylCysteine (NAC; n=21 fish) or 5 µM
Buthionine Sulfoximine (BSO; n=28 fish), or a combination of the two (n=40 fish) for
24 hours prior to MCB staining and imaging. The fluorescence intensity was
compared to untreated controls (n=35 fish). Values are mean + SEM fluorescence
intensities normalized to the mean fluorescence intensity of yolk of untreated
controls, combined from at least 2 independent experimental runs. Different letters
indicate statistically significant differences (p ≤ 0.05), as determined by a one-way
ANOVA followed by a Tukey-Kramer post-hoc, across the indicated structure. Right:
Heatmaps of monochlorobimane fluorescence observed in embryos exposed to the
stated treatment.
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Figure 2.4: MCB responds robustly to peroxide mediated GSH depletion.
Zebrafish embryos aged 48 hpf were exposed to 750 µM tert-Butylhydroperoxide
for 10 (n = 26 fish) or 30 (n = 25 fish) minutes immediately prior to MCB staining
and imaging. The fluorescence intensity was compared to untreated controls (n = 27
fish). Values are mean + SEM fluorescence intensities normalized to the mean
fluorescence intensity of yolk of untreated controls, combined from at least 2
independent experimental runs. Different letters indicate statistically significant
differences (p ≤ 0.05), as determined by a one-way ANOVA followed by a TukeyKramer post-hoc, across the indicated structure. Right: Heatmaps of MCB
fluorescence observed in embryos exposed to the stated treatment.
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Figure 2.5: MCB responds robustly to menadione induced GSH depletion.
Zebrafish embryos aged 48 hpf were exposed to 10 µM Menadione for 1 hour (n=35
fish) immediately prior to MCB staining and imaging. The fluorescence intensity was
compared to 0.01% DMSO controls (n=24 fish). Values are mean + SEM fluorescence
intensities normalized to the mean fluorescence intensity of yolk of untreated
controls, combined from at least 2 independent experimental runs. Stars indicate
statistically significant differences (p≤0.05), as determined by a two-tailed t-test,
across the indicated structure. Right: Heatmaps of monochlorobimane fluorescence
observed in embryos exposed to the stated treatment.
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Figure 2.6: Developmental PFOS exposure induces dose and structure
dependent changes in MCB fluorescence. (A) Zebrafish embryos aged 48 hpf
were exposed to 3.2 µM (n = 31 fish) or 32 µM (n=31 fish) Perfluorooctane sulfonic
acid (PFOS) from 3 hpf until MCB staining and imaging. The fluorescence intensity
was compared to 0.01% DMSO treated controls (n=35 fish). (B) Zebrafish embryos
aged 72 hpf were exposed to 3.2 µM (n = 32) or 32 µM PFOS (n=35 fish) from 3 hpf
until MCB staining and imaging. Fluorescence intensity was compared to 0.01%
DMSO treated controls (n=35 fish). Values are mean + SEM fluorescence intensities
normalized to the mean fluorescence intensity of yolk of untreated controls,
combined from at least 2 independent experimental runs. Different letters indicate
statistically significant differences (p ≤ 0.05), as determined by a one-way ANOVA
followed by a Tukey-Kramer post-hoc, across the indicated structure. Right:
Heatmaps of MCB fluorescence observed in embryos exposed to the stated
treatment.

49

Figure 2.7: Developmental MEHP exposure induces structure and age
dependent changes in MCB fluorescence. (A) Zebrafish embryos aged 48 hpf
were exposed to 200 µg/L Mono(2-ethylhexyl) phthalate (MEHP) (n = 34 fish) or
0.01% DMSO (n = 23 fish) from 3 hpf until MCB staining and imaging. (B) Zebrafish
embryos aged 72 hpf were exposed to 200 µg/L MEHP (n = 30 fish) or 0.01% DMSO
(n = 24 fish) from 3 hpf until MCB staining and imaging. Values are mean + SEM
fluorescence intensities normalized to the mean fluorescence intensity of yolk of
untreated controls, combined from at least 2 independent experimental runs. Stars
indicate statistically significant differences (p ≤ 0.05), as determined by a t-test,
across the indicated structure. Right: Heatmaps of MCB fluorescence observed in
embryos exposed to the stated treatment.
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Figure 2.8: MCB fluorescence patterns in the zebrafish eleutheroembryo aged
96 hpf align with known reduced GSH concentrations in a 13-week old human
fetus. † Indicates data from Raijmakers et al, 2001 [126]. * Indicates data from Fig.
2.1; in the zebrafish eleutheroembryo, it was not possible to distinguish the stomach
from the small intestine.

51

Figure 2.9: DAPI channel autofluorescence in zebrafish embryos at different
developmental stages. (A) Raw, unprocessed images of MCB stained embryos used
to generate heatmaps presented in Fig. 2.1. (B) Heatmaps of background
autofluorescence in unstained zebrafish embryos at 24, 48, 72 and 96 hpf.
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Figure 2.10: A 30 minute ETA exposure is insufficient to elicit a change in MCB
fluorescence. Zebrafish embryos aged 48 hpf were exposed to 100 µM Ethacrynic
Acid for 30 minutes (n = 31 fish) immediately prior to MCB staining and imaging.
The fluorescence intensity was compared to 0.1% DMSO treated controls (n=26).
Values are mean + SEM fluorescence intensities normalized to the mean
fluorescence intensity of yolk of untreated controls, combined from at least 2
independent experimental runs. Data were not statistically significant (t-test).
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Figure 2.11: Concentration of DMSO affects MCB fluorescence. Zebrafish
embryos aged 48 hpf were exposed to 0.01% DMSO (n = 27 fish) or 0.1% DMSO (n =
26 fish) for 1 hour immediately prior to MCB staining and imaging. Values are mean
+ SEM fluorescence intensities normalized to the mean fluorescence intensity of
yolk of untreated controls, combined from at least 2 independent experiments. Stars
indicate statistically significant differences (p ≤ 0.05), as determined by a t-test
across the indicated structure.
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Figure 2.12: Variable gut autofluorescence in zebrafish embryos aged 72 hpf.
Autofluorescence heatmaps of zebrafish embryos from the same clutch aged 72 hpf
exposed to either 0.01% DMSO (Embryo 1 and 2) or 200 µg/L (Embryo 3 and 4)
from 3 hpf until imaging.
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Table 1.1: Fluorescence Intensity Values of Stained and Unstained Embryos

Values represent the background corrected mean ± SEM fluorescence of embryos
unstained (-) or stained (+) with MCB at 24 (n=16), 48 (n=27), 72 (n=29) and 96
(n=27) hpf. (n=8-10 fish for unstained conditions.)
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Table 1.2: Fluorescence Intensity Values of Stained and Unstained Embryos
Exposed to Glutathione Modulators

Values represent the background corrected mean ± SEM fluorescence of embryos
unstained (-) or stained (+) with MCB at 48 hours post fertilization following the
stated treatment for 24 hours. (n= 23-36 fish for stained conditions and n=8-10 fish
for unstained conditions.)
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CHAPTER 3

MODULATING GLUTATHIONE THIOL STATUS ALTERS PANCREATIC Β-CELL
MORPHOGENESIS IN THE DEVELOPING ZEBRAFISH (DANIO RERIO) EMBRYO

3.1 Abstract
Pancreatic islet growth is perturbed by redox-active chemicals, but mechanisms
governing this are unknown. We used zebrafish (Danio rerio) embryos to investigate
roles of glutathione (GSH; predominant cellular redox buffer) and the transcription factor
Nrf2a (Nfe2l2a; zebrafish Nrf2 co-ortholog) in islet morphogenesis. We delineated
critical windows of redox susceptibility to β-cell morphogenesis, and, visualized Nrf2a
expression in the pancreas using whole-mount immunohistochemistry at 96 hours post
fertilization (hpf). Chemical GSH modulation at 48 hpf induced significant islet
morphology changes persistent through 96 hpf. Decreased β-cell cluster area at 96 hpf
resulted from exposures to prooxidants tert-Butylhydroperoxide (77.6 μM; 10-minutes at
48 hpf) and tert-Butylhydroquinone (1 μM; 48-56 hpf). Conversely, exposures at this
stage to antioxidants N-AcetylCysteine (100 μM; 48-72 hpf) and sulforaphane (20 μM;
48-72 hpf) significantly increased islet areas. Nrf2a was also stabilized in the islet at this
stage: 10-minute exposures to 77.6 μM tert-Butylhydroperoxide significantly increased
Nrf2a protein in the islet, compared to control islets that lack Nrf2a; 10-minute exposures
to higher (776 μM) tert-Butylhydroperoxide concentration induced Nrf2a in the entire
pancreas. We assessed functional implications of Nrf2a changes using biotinylated-GSH
to visualize in situ protein glutathionylation. Islets had high protein glutathionylation,
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indicating oxidized GSH pools, congruent with low Nrf2a levels. The 10-minute high
(776 μM) tert-Butylhydroperoxide exposure (induced Nrf2a globally) decreased global
protein glutathionylation. Mutant fish expressing inactive Nrf2a were protected against
abnormal islet morphology. Our data indicate disrupted redox homeostasis during
pancreatic β-cell development impacts morphogenesis, with implications for disease
states later in life.

3.2 Significance Statement
Despite redox dysfunction being well-characterized as an underlying cause of
pancreatic β-cell dysfunction and diabetes, there is little known about redox signaling
during β-cell morphogenesis. Here, we demonstrate the decreased antioxidant defenses of
the developing β-cell, and the specific sensitivity of this cell type to endogenous and
exogenous redox stressors. Our work identifies a potential molecular target (Nrf2a) that
induces abnormal β-cell morphology in response to redox disruptions. Moreover, our
findings implicate that developmental exposure to exogenous stressors at distinct
windows of susceptibility could diminish the reserve capacity of β-cells, rendering them
vulnerable to later-life stresses increasing the likelihood of developing diabetes.

3.3 Introduction
With a 100 million patients, and an annual cost of $327 billion in the United
States alone, diabetes is a pressing healthcare challenge [156]. Though a complex
multifactorial group of diseases, pancreas dysfunction is a hallmark of all forms of
diabetes. The pancreas is largely comprised of exocrine tissue that secretes enzymes
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to digest biomacromolecules; the endocrine islets of Langerhans occupy
approximately 2% of the total pancreas by volume, with pancreatic β-cells and αcells secreting insulin and glucagon respectively to regulate blood glucose
homeostasis [157]. Pancreas development in the embryo has been shown to be
impaired by environmental conditions including exposures to toxic chemicals,
resulting in shortened pancreatic tail lengths, reduced β-cell mass, or aberrant
morphologies of islet structure [71, 74, 89, 158], but the mechanisms involved are
not understood. Pancreatic β-cells in particular appear to be especially sensitive to
chemicals that cause redox disruptions, likely related to the fact that these cells rely
on reactive oxygen species (ROS) as cellular signals during differentiation and to
stimulate insulin secretion [159]. To facilitate these functions, β-cells possess
inherently lower antioxidant capacities [53, 160]. Therefore, chemical-induced
redox stress, particularly during the sensitive period of embryonic development,
could lead to disruptions in pancreatic morphogenesis and functional consequences
related to glucose homeostasis and pancreatic insufficiency. However, thus far our
understanding of the redox signaling of pancreatic β-cells in the embryo is limited.
Of the many redox signaling systems employed by the developing vertebrate
embryo [11], glutathione (GSH), in tandem with its oxidized form glutathione
disulfide (GSSG) provides the predominant redox buffering system [4, 161].
Disruptions of the GSH system during organogenesis are known to induce adverse
outcomes like cell migration defects, premature differentiation, apoptosis and organ
agenesis [11, 15, 81]. In the zebrafish (Danio rerio), GSH levels in the developing
pancreas are especially susceptible to redox modulators when compared to other
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developing organ systems [76]. Moreover, between 24 and 48 hours post
fertilization (hpf), the zebrafish enters the pharyngula stage – a period of rapid
organogenesis [112]. During this time of heightened differentiation, the GSH redox
potential, defined by the ratio of reduced GSH to oxidized GSSG, shifts from reducing
at 24 hpf to oxidizing at 48 hpf [20]. The endocrine and exocrine pancreas both
differentiate during this time, with the ventral and dorsal pancreatic ducts fusing
around 48 hpf (Fig. 1) [162]. Given the specific, spatiotemporal changes in GSH
levels of the developing embryo [20, 76], coupled with intricate developmental
processes that dictate pancreatogenesis, we hypothesized disparate resilience of the
pancreas to redox disruptions at distinct developmental timepoints.
The pool of reduced GSH also serves as the substrate for the glutathione-stransferase (GST) enzyme superfamily, which glutathionylates proteins and
xenobiotics to regulate metabolism. Protein S-glutathionylation, a post-translational
modification that activates or inactivates functional domains, provides cells a
powerful control over homeostasis [163, 164]. GST expression, along with a
majority of cellular antioxidant defense genes is under the control of the Nuclear
Factor Erythroid 2-like 2 (NFE2L2 or Nrf2) transcription factor [26]. Nrf2 is known
to be upregulated in cancer cells where it confers cytoprotective properties, and has
thus largely been studied as a potential therapeutic target [165, 166]. However, a
growing body of literature has established that normal Nrf2 signaling plays
important roles in embryonic development [19, 90, 167, 168]. A multitude of redox
stressors – endogenous metabolic byproduct ROS, and, exogenous xenobiotics – can
deplete cellular GSH pools and activate Nrf2 [18, 90]. Since the developing pancreas
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is susceptible to GSH depletion [76], it is a sensitive target organ for all these redox
stressors. Moreover, redox dysfunction is implicated as a mechanism of pancreatic
β-cell dysfunction underlying diabetes with Nrf2 activation protecting against the
onset of diabetes [58, 70, 169]. Despite evidence for redox dysfunction being
fundamental to endocrine pancreatic disruption across multiple model systems, the
molecular pathways underlying this remain unknown. We hypothesized that
glutathione depletion disrupts normal Nrf2 signaling in embryonic pancreatic βcells, leading to aberrant morphologies.
Here, we use gain-of-function and loss-of-function experiments to
demonstrate the sufficiency and necessity of Nrf2 disruption for aberrant pancreatic
development in the zebrafish (Danio rerio) embryo. Zebrafish embryos serve as an
excellent model for this study, owing to their high fecundity and rapid exogenous
development. Pancreatic function and development is conserved among zebrafish
and humans; the zebrafish Nrf2 co-ortholog to human Nrf2 is Nrf2a [76, 167, 170].
We identify distinct temporal windows of redox susceptibility governing pancreatic
organogenesis in vivo and demonstrate the lowered antioxidant defenses of the
endocrine pancreas in situ. We also present a novel application of biotinylated
glutathione ethyl ester (BioGEE) to probe protein glutathionylation levels in whole
zebrafish (Danio rerio) embryos in situ, allowing for the first time, for the spatial
resolution of an important post-translational modification at the whole organism
level.
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3.4 Materials and Methods
See SI Appendix for a detailed account of materials and methods. Briefly,
zebrafish husbandry and embryo sampling were done using standard, previously
described methods [76]. All embryos were dechorionated using watchmakers
forceps and dosed with stated chemicals for stated durations in borosilicate glass
scintillation vials at a density of 1 ml Danieau’s/1 embryo. Where applicable, the
final DMSO concentration was 0.01%. For immunohistochemistry (IHC)
experiments, heat antigen retrieval at 70°C for 20 minutes followed by acetone
permeabilization for 8 minutes were done prior to incubation in the previously
described anti-Nrf2a antibody [89]. Live embryos and larvae were imaged using an
upright compound microscope; IHC embryos and larvae were imaged using a
confocal microscope.

3.4.1 Chemicals and Reagents
Paraformaldehyde (PFA; Catalog # AAJ19943K2), Phosphate Buffered Saline
(PBS; Catalog #AAJ75889AE), Methanol (Catalog #A412-4), Tween-20 (Catalog
#BP337-100), and Dimethyl Sulfoxide (DMSO; Catalog #BP231-1) were purchased
from Fisher Scientific (Pittsburgh, PA, USA). Tert-Butyl hydroperoxide (tBOOH;
Catalog #A13926AP) and N-acetyl-L-cysteine (NAC; Catalog #A1540914) were
purchased from Alfa Aesar (Ward Hill, MA, USA). Tert-butyl hydroquinone (tBHQ;
Catalog #AC150820050) was purchased from Acros Organics (NJ, USA). DLSulforaphane (SFN; Catalog #S4441) was purchased from Millipore-Sigma
(Burlington, MA, USA). Vectashield Antifade Mounting Medium with DAPI (Catalog
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#H-1200) was purchased from Vector Laboratories (Burlingame, CA, USA). Chicken
Anti-Rabbit IgG AlexaFluor 594 (Catalog # A-21442), AlexaFluor 594 tagged
Streptavidin (Catalog # S32356) and Biotinylated Glutathione Ethyl Ester (BioGEE;
Catalog #G36000) were purchased from Invitrogen (Carlsbad, CA, USA).

3.4.2 Fish Husbandry and Embryo Sampling
Tg(insa:eGFP) and Tg(gcga:eGFP) transgenic zebrafish on wild type (AB)
background were used for in vivo observation of the β-cells and α -cells,
respectively. Homozygous wild type (nrf2a+/+) and nrf2afh318/fh318 crossed with
Tg(insa:eGFP) zebrafish embryos on an AB strain background were used to
investigate the Nrf2 pathway in the developing β-cells. All breeding adults were
maintained on an automated Aquaneering (San Diego, CA, USA) system in
accordance with the Guide for the Care and the Use of Laboratory Animals of the
National Institutes of Health and with approval from the University of
Massachusetts Amherst Institutional Animal Care and Use Committee (Animal
Welfare Assurance Number A3551-01). The fish were housed at 28.5 °C on a 14 h
light, 10 h dark cycle, and fed GEMMA Micro 300 (Skretting, Westbrook, ME, USA)
twice daily. Large breeding tanks were setup with approximately 20 adult female
and 10 adult male fish. Embryos were collected 1 h post fertilization, washed and
screened for fertilization status and staged according to Kimmel et al. [112]. The
embryos were dechorionated at 24 hpf and reared in borosilicate glass scintillation
vials with 1 ml 0.3x Danieau's per embryo.
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3.4.3 Chemical Exposures
To investigate how the timing of pro- and antioxidant exposures impacts the
development of the endocrine pancreas, zebrafish eleutheroembryos were exposed
to NAC (100 μM; 24 h), SFN (20 μM; 24), tBOOH (77.6 μM or 776 μM; 10-minutes),
tBHQ (1 μM; 6 h), water or DMSO (0.01%) control at either 24, 48, or 72 hpf. All
eleutheroembryos were manually dechorionated using watchmakers forceps at 24
hpf. Following exposures, fish were thoroughly washed and maintained in 0.3x
Danieaus for microscopy or immunohistochemistry at 96 hpf. 3.2 μM PFOS and
concurrent NAC exposures were started at 3 hpf. Embryos were dechorionated at 24
hpf, with exposures refreshed daily until 96 hpf, when embryos were collected for
immunohistochemistry.

3.4.4 Immunohistochemistry
Embryos were fixed in 4% PFA in PBS for 24 hours at 4°C at a ratio of 15
embryos/ml PFA. Embryos were rinsed in 0.1 % PBS-Tween-20 (PBST), and stored
in 100% methanol at – 20°C overnight. Samples were rehydrated using methanolPBST gradients. Heat antigen retrieval was done by heating the rehydrated samples
at 70°C for 20 minutes. Immediately following heat retrieval, samples were
permeabilized using ice-cold acetone for 8 minutes. Samples were blocked using 5%
Sheep’s serum in PBST for 2 hours at room temperature, followed by the previously
characterized anti-Nrf2a antibody (1:1000 in block) for 48 hours at 4°C [89].
Samples were placed in Alexa-594 tagged anti-rabbit antibody (1:5000 in block)
overnight. Samples were washed with PBST and stored in Vectashield containing
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DAPI at 4°C until imaging. A subset of embryos were run through the entire
immunohistochemistry (IHC) procedure, without using any primary antibody as a
control for non-specific binding of secondary antibody. The most robust response
for Nrf2a, seen with a 10-minute exposure to 77.6 μM tBOOH, was included as a
positive control in every IHC procedure experiment.
For BioGEE samples, embryos were exposed to 100 μM BioGEE for 2 hours prior
to fixation. Following fixation, all steps were identical until blocking. Post-blocking,
samples were placed in AlexaFluor 594 tagged Streptavidin (1:5000) for 1 hour at
room temperature. Samples were then washed with PBST and stored in Vectashield
containing DAPI at 4°C until imaging. A subset of embryos were run through the
entire immunohistochemistry procedure, without exposing them to BioGEE as a
control for non-specific binding of AlexaFluor 594 tagged Streptavidin.

3.4.5 Microscopy
Larvae were imaged at 96 hpf to observe the effects of exposure on the
development of the primary islet, using an upright Olympus compound fluorescence
microscope equipped with a Zeiss Axiocam 503 camera and Zen analysis software
(Zeiss, USA). Fish were briefly anesthetized in 0.3x Danieaus containing MS-222 and
staged laterally in 3% methylcellulose to optimize visualization of the endocrine
islet. Images were captured using monochrome and GFP fluorescence filters at 2X,
5X, and 10X magnification to assess gross morphology and islet structure. Images
were blinded, then analyzed using Zen (Zeiss) analysis software. Islet area was
determined by tracing the perimeter of the cell cluster on the 10X GFP images, and
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the area was calculated by the software. Islet morphology was also assessed to
quantify the frequency of islet variants such as hypomorphic, fragmented, stunted,
hollow islets, or ectopic endocrine cells [57].
Larvae with immunohistochemistry for Nrf2a or BioGEE were imaged using a
Nikon A1 Spectral Detector Confocal microscope equipped with 405 nm, 488 nm,
561 nm and 640 nm laser lines. Z-stacks were taken through the entire pancreas,
using a 40x objective, 0.3 pixels equated 1 μm when imaging the whole pancreas
and 0.06 pixels equate 1 μm when imaging islet insets, scale bars represent 20 μm.
Sequence scanning was used to eliminate cross-channel fluorescence overlap.
Images presented here are collapsed max-intensity projections, flipped horizontally
to reflect the biological orientation of the pancreas. Images were blinded and graded
for expression patterns based on OECD guidelines [117, 186].

3.4.6 Statistics
To assess statistical significance of islet morphology variants, Analysis of
Variance (ANOVA) tests, followed by a Fishers Least Significant Differences (LSD)
Post-Hoc Test, were performed in JMP Pro 14. All experiments were repeated for 57 biological replicates (total n>30 fish). To assess statistical significance of
immunohistochemistry expression patterns, χ2 tests were carried out using Excel,
statistical significance was set to a p-value of 0.05. All experiments were repeated
for 4-5 biological replicates (total n>12 fish); meeting or exceeding OECD guidelines
[117, 186].
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3.5 Results

3.5.1 Endocrine pancreatic organogenesis is governed by distinct
spatiotemporal windows of redox susceptibility
To delineate critical windows of pancreatic susceptibility to redox exposure,
we exposed zebrafish embryos to small molecules with either pro or anti-oxidant
activities at 24, 48 or 72 hpf and imaged their endocrine pancreata at 96 hpf, when
they are formed and functional. The redox modulators used were N-AcetylCysteine
(NAC) – which bolsters cellular GSH pools, tert-Butylhydroperoxide (tBOOH) – a ROS
that depletes cellular GSH, and, Sulforaphane (SFN) and tert-ButylHydroquinone
(tBHQ) – both Nrf2a activators. Concentrations were selected that were below any
observed lethality, overt morphological deformities, or impacts on growth. NAC and
SFN exposures at 24 hpf did not induce significant changes in either β-cell or α-cell
areas when analyzed at 96 hpf. The 10-minute 77.6 μM tBOOH exposure induced
decreased β-cell area by 18% (p<0.05), the 6-hour 1 μM tBHQ exposure increased
islet variant frequency by 400% (p<0.05%) (Fig. 1). The pancreas was most sensitive
to redox modulation at 48 hpf, with all treatments inducing significant changes in βcell area (Fig. 1). The antioxidants NAC and SFN induced a 20% and 25% increase in
β-cell area respectively (p<0.05). Notably, the 10-minute 77.6 μM tBOOH exposure at
48 hpf was sufficient to cause a persistent 25% decrease in β-cell area when
measured at 96 hpf, along with a 1000% increase in the incidence of islet variants
(Fig. 1; p<0.05). tBOOH and tBHQ exposures at 48 hpf were also the only treatments
where the α-cells showed a response. There was a 5% reduction in α-cell area upon
these exposures. (Supp. Fig. 1). This likely reflects the 25% reduction in β-cell area,
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as β-cells form the core of the spherical islet. Exposures at 72 hpf induced similar
changes as exposures at 48 hpf, however, the magnitude of changes was much smaller
compared to the 48 hpf exposure window (Fig. 1).

3.5.2 Endocrine pancreas has low endogenous antioxidant defenses during
development
We characterized antioxidant defense levels of the endocrine pancreas using
anti-Nrf2a antibodies and BioGEE. None of the fish had Nrf2a expression in the islet
(p<0.05), and 100% had higher levels of protein glutathionylation (p<0.05) (Fig. 2).
In contrast, Nrf2a was robustly detected in the exocrine pancreas, indicating the
efficiency of the Nrf2a antibody and IHC procedure.

3.5.3 Peroxide induced GSH depletion activates Nrf2a and impacts protein
glutathionylation in the pancreas
Given the heightened sensitivity of the endocrine pancreas to a 10-minute 77.6
μM tBOOH exposure at 48 hpf, we investigated Nrf2a dynamics and protein
glutathionylation in response to tBOOH treatment. A 10-minute 77.6 μM tBOOH
exposure at 48 hpf resulted in 100% fish expressing Nrf2a in pancreatic β-cells,
sustained through 96 hpf (p<0.05; Fig. 3). This was accompanied by a sustained
increase in protein glutathionylation in the endocrine and exocrine pancreata of a
100% of the fish (p<0.05; Fig. 3). The increase in Nrf2a expression occurs between
one to two hours post treatment, and is restricted to β-cells (Supp. Fig. 2). A higher
776 μM tBOOH exposure at 48 hpf resulted in the entire pancreas showing elevated
levels of Nrf2a, accompanied by decreased global protein glutathionylation (p<0.05;
Fig. 3). Both 77.6 and 776 μM tBOOH are sublethal doses with no overt toxic or growth
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effects in the zebrafish embryo [19, 76]. A 24 hour pretreatment with 100 μM NAC,
which bolsters cellular GSH pools rescued the aberrant Nrf2a expression effects seen
with both 77.6 μM and 776 μM tBOOH in 100% of the fish, indicating GSH can protect
against Nrf2a stabilization in pancreatic β-cells (Fig. 3). In Nrf2a m/m fish, which
carry a mutation in the DNA-binding domain of Nrf2a, 77.6 μM tBOOH did not
stabilize Nrf2a (Fig. 4). An opposite result was seen at the 10-fold higher, 776 μM
tBOOH treatment. This treatment stabilized Nrf2a in the mutant fish (Fig. 3), in a
pattern similar to the Nrf2a wildtype fish (Fig. 3). Concordant with transcriptional
inactivity of Nrf2a in the mutant embryos, we did not see loss of protein
glutathionylation as in wildtype embryos. This indicates a role for other transcription
factors in the activation of Nrf2a in zebrafish.

3.5.4 SFN and tBHQ impact Nrf2a expression and protein glutathionylation
Upon exposure to the Nrf2a activators tBHQ and SFN, a 100% of the Nrf2a
wt/wt embryos demonstrated a near total loss of Nrf2a expression in both the
endocrine and exocrine pancreas (p<0.05; Figs. 4 and 5). This loss of Nrf2a expression
was accompanied by increased levels of protein glutathionylation (p<0.05; Figs. 4 and
5). In contrast, Nrf2a m/m fish showed increased levels of Nrf2a and increased levels
of protein glutathionylation in the pancreas (p<0.05; Figs. 4 and 5). In Nrf2a mutant
pancreata, protein glutathionylation levels did not increase to the same degree as in
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the wildtype, indicating changes in glutathionylation are occurring downstream of
Nrf2a.

3.5.5 Nrf2a m/m fish are protected against aberrant islet morphologies
To determine the contribution of Nrf2a in the development of aberrant islet
morphologies we exposed Nrf2a wt/wt and Nrf2a m/m embryos to 77.6 μM tBOOH
for 10 minutes at 48 hpf, and measured fish length, β-cell area and hypomorphic islets
(characterized as previously described) (29). This exposure was chosen as it elicited
the most dramatic response with regards to both morphology changes and Nrf2a
activation. We found that wildtype embryos were more susceptible to decreases in
both β-cell area, and the incidence of hypomorphic islets (Fig. 6). Nrf2a wt/wt
embryos showed a 13% reduction in β-cell area (p<0.05) and a 300% increase in
hypomorphic islets. Nrf2a m/m fish on the other hand, showed no effects with either
of these parameters (Fig. 6). This demonstrates that Nrf2a is essential for tBOOH
mediated changes in β-cell morphology. We also measured fish length for both
wildtype and mutant embryos to ensure observed changes were β-cell specific, as
opposed to overall decreased growth. We found no changes in fish length (Fig. 6).

3.6 Discussion
Pancreatic development utilizes a dynamic network of redox-sensitive
signaling pathways which dictate organ morphogenesis [58, 169]. Interrupting
these pathways can induce abnormal pancreatic morphologies, potentially
predisposing individuals to adverse health outcomes [71, 74, 89, 158]. In this study,
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we characterize, for the first time, the low GSH buffering capacity and Nrf2a protein
levels in the developing endocrine pancreas. We demonstrate redox active
xenobiotic exposures at specific developmental timepoints induce sustained
disruptions in redox signaling in β-cells. Our findings are indicative of a reduction in
the reserve redox capacity of β-cells, with important implications for impaired β-cell
function later in life.
We found distinct windows of pancreatic β-cell susceptibility to redox
modulation with embryos aged 48 hpf being most susceptible to abnormal
pancreatic morphologies. In the zebrafish embryo, the redox potential is oxidizing
and GSH levels in the developing gut decrease at 48 hpf, providing a potential
explanation for the significance of this timepoint (Fig. 1) [20, 76]. Of all the
parameters measured, β-cell cluster area is most impacted, fish length is not
affected and α-cell cluster area decreases slightly, indicating the inherent
susceptibility of β-cells to redox disruptions (Fig. 1; Fig. 6; Supp. Fig. 1). The redox
sensitivity of pancreatic β-cells can also be explained, in part, by the lack of Nrf2a,
and the higher levels of protein glutathionylation in the pancreatic islet (Fig. 2).
Elevated glutathionylation is a marker of oxidative stress, and an oxidizing GSH
redox potential [163]. Oxidizing redox potentials equate to lower levels of reduced
GSH, and consequently, lower buffering capacity against oxidative insults.
The prooxidant tBOOH induced the most dramatic changes in β-cell
morphology, with a short 10-minute treatment at 48 hpf inducing changes sustained
two days later at 96 hpf (Fig. 3). This is concordant with the fact that a 10-minute
tBOOH treatment at 48 hpf depletes 50% of the GSH pool in the zebrafish embryo,
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and, the GSH pools within the embryo start to recover about 1.5 hours post
treatment [76]. We found that Nrf2a expression increases 2 hours post tBOOH
treatment, and stays increased through 96 hpf (Supp Fig. 2; Fig 3). This implies the
existence of a threshold of GSH depletion that triggers Nrf2a expression. Given the
divergent GSH levels of different cell lineages, this internal setpoint is likely
different for different cell types, our data indicate it to be especially low for
pancreatic β-cells.
The exocrine pancreata of fish exposed to 77.6 μM tBOOH lack the increased
levels of Nrf2a expression whereas exposure to 776 μM tBOOH, a 10-fold higher
dose, results in global Nrf2a expression (Fig 3). Additionally, a 100 μM NAC
pretreatment, which bolsters cellular GSH, rescues aberrant Nrf2a expression at
both doses of tBOOH. This lends credence to an internal GSH threshold, artificially
increasing GSH levels in β-cells raises this threshold and inhibits prooxidant
mediated Nrf2a activation. Exposing Nrf2a m/m embryos, which carry a mutation in
the DNA-binding domain of Nrf2a, to 77.6 μM tBOOH does not elicit an increase in
Nrf2a protein expression in the islet. In contrast, the 10-fold higher 776 μM tBOOH
exposure does induce global Nrf2a expression in the pancreas (Fig 3). This indicates
that Nrf2a self-regulates its transcription and translation in response to tBOOH
mediated GSH depletion until a setpoint. However, once GSH drops below this
internal setpoint, Nrf2a transcription and translation is triggered; in the zebrafish,
this could potentially be activated by Nrf1b or Nrf2b, co-orthologs of Nrf2a [19,
170]. Transcriptional regulation of Nrf2 by many oncogenes in multiple model
organisms is also well-characterized [171]. Nrf2a expression increases are
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accompanied by decreased protein glutathionylation (Fig. 3). This is readily
apparent in embryos exposed to 776 μM tBOOH, where the global increase in Nrf2a
expression led to a global decrease in protein glutathionylation levels (Fig. 3).
Another potential explanation for the sustained high levels of Nrf2a seen in
the β-cells in response to tBOOH exposure could be the mechanism by which tBOOH
is detoxified. Besides GSH depletion, tBOOH serves as a substrate for glutathione
peroxidase 1 and glutathione peroxidase 4 [172]. In pancreatic β-cells Gpx
expression levels are very low, and slower tBOOH catalysis likely leads to sustained
secondary oxidative stress [160]. Gpx4 overexpression in β-cells has been
demonstrated to reduce the generation of lipid hydroperoxides (including tBOOH),
and reverse diabetic phenotypes [173, 174]. Gpx expression can also be triggered by
Nrf2a, with Gpx reporters being activated by the canonical Nrf2a activators tBHQ
and SFN [175]. Thus, the elevated Nrf2a expression is likely a transcriptional
response by the embryo to try and return to homeostatic conditions by neutralizing
tBOOH. In the exocrine pancreas, the innate antioxidant defenses coupled with
Nrf2a are sufficient to neutralize tBOOH; in the endocrine pancreas the lower
antioxidant defenses delay this recovery, leading to elevated Nrf2a expression levels
two days later.
Interestingly, tBHQ and SFN, both activators of Nrf2a caused a near total loss
of Nrf2a expression in both the endocrine and exocrine pancreas of exposed fish,
indicating that these exposures target Nrf2a for ubiquitination and degradation in
pancreatic tissue. This lack of Nrf2a expression was accompanied by a drastic
increase in protein glutathionylation (Figs. 4 and 5). These results are congruent
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with our findings with 776 μM tBOOH, where increased Nrf2a was accompanied by
decreased glutathionylation. In Nrf2a m/m fish, we saw high levels of Nrf2a
expression upon tBHQ and SFN exposure, but, this did not impact protein
glutathionylation levels, which remained high. Thus, Nrf2a activity is necessary for
changes in protein glutathionylation.
In the zebrafish embryo, exposure to a ten-fold higher dose of tBHQ (10 μM)
than the dose we used (1 μM), is insufficient to induce Nrf2a expression in 48 hpf,
72 hpf and 96 hpf embryos [176]. Genes downstream of Nrf2a, especially those
involved in GSH synthesis are induced by 300%, but Nrf2a itself is not induced
[176]. Among the highest induced genes are the heat shock proteins Hsp70 and
Hsp90, the induction of Hsp70 in response to tBHQ mediated Nrf2a activation has
been confirmed in multiple studies [19, 170, 176]. Both these proteins help stabilize
protein folding, by either delaying completion of protein folding, or, accelerating
proteasomal degradation of misfolded proteins [177]. Thus, changes in the total
protein levels of Nrf2a might be masked by overexpression of Hsp70 and Hsp90.
Given the increase in protein glutathionylation, it is apparent that tBHQ and SFN
induce high levels of oxidative stress, arising at least in part due to decreased Nrf2a
levels (Fig. 5).
Nrf2a mutant embryos showed increased Nrf2a expression levels upon tBHQ
and SFN exposures (Figs. 4 and 5). This implies that the loss of Nrf2a expression
seen in Nrf2a wildtype embryos upon these exposures is mediated by a downstream
target of Nrf2a. Nrf2a triggered expression of Hsp70 and Hsp90 could potentially be
leading to lower levels of Nrf2a protein in wildtype embryos, the mutant embryos
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are unable to trigger this transcriptional response and thus, maintain higher levels
of Nrf2a [19, 170, 176]. Another possibility is that wildtype embryos recover Nrf2a
levels sometime post 96 hpf. However, the exact reasons as to why tBHQ and SFN
induce sustained decreases in pancreatic Nrf2a expression remain unclear, and,
merit further investigation.
Sustained changes in expression patterns of Nrf2a seem to underlie
pancreatic islet morphology defects. Nrf2a mutant embryos were protected against
the abnormal islet morphologies seen with 77.6 μM tBOOH, whereas wild-type
embryos expressing functional Nrf2a showed a 13% decrease in islet area and a
300% increase in incidence of hypomorphic islets. The 10-fold higher 776 μM
tBOOH exposure however, induced similar defects in both wild type and mutant fish,
indicating that beyond a degree of GSH depletion, other redox defense systems
besides Nrf2a are activated. Fish length was unaffected, indicating the β-cell
specificity of this effect (Fig. 6). Given that Nrf2a mutant embryos are protected
against aberrant Nrf2a expression patterns in response to redox stresses (Figs. 3-5),
aberrant Nrf2a expression during development seems necessary for disrupted
endocrine pancreatogenesis.
A possible mechanism for this is Nrf2a mediated glutathionylation changes,
evidenced by the fact that 776 μM tBOOH triggered Nrf2a expression in Nrf2a m/m
embryos but did not decrease protein glutathionylation as seen in Nrf2a wt/wt
embryos (Fig. 3). Differential glutathionylation is crucial from a developmental
perspective, as protein glutathionylation is a well-characterized mechanism of
transcriptional and functional regulation of proteins [164]. Within pancreatic β-
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cells, reversible glutathionylation of the inner mitochondrial membrane protein,
Uncoupling Protein – 2, is necessary for glucose stimulated insulin secretion, and
consequently, β-cell function [178]. Moreover glutathionylation of Kelch Like ECH
Associated Protein 1 (Keap1), the cytosolic repressor of Nrf2, increases cellular Nrf2
protein levels [179].This glutathionylation is catalyzed by GSTπ, a downstream
target of Nrf2a; previously, we have shown altered GSTπ activity in the developing
zebrafish pancreas upon exposure to multiple redox stressors including tBOOH [76].
GSTπ also silences the JNK signaling pathway via protein glutathionylation [180].
This is notable in the context of pancreatic β-cells, as the pancreatic and duodenal
homeobox-1 (PDX1) transcription factor is known to be regulated by JNK signaling.
PDX1 is essential for the differentiation of pancreatic β-cells, and, controls the
expression of insulin [162, 181]. Oxidative stress induced disruption of PDX1
signaling, a hallmark of diabetes, can be rescued by restoration of normal JNK
signaling [182].
Nrf2a signaling is highly consistent in the developing zebrafish pancreas,
with 23 embryos displaying similar expression patterns (Fig. 2). We find that
multiple redox modulators induce sustained disruptions to these expression
patterns (Figs. 3-5). This sustained departure from normal signaling could have
severe ramifications for the development of disease states, with altered baseline
Nrf2a levels rendering pancreatic β-cells vulnerable to subsequent redox active
xenobiotic exposures. Concordant with our results, in healthy human pancreatic βcells Nrf2 is largely absent; Nrf2 activation is indicated as a coping mechanism for
stressed β-cells, accompanied by reduced insulin secreting capacity [183, 184].
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Thus, while activation of Nrf2 in B-cells can promote cell survival, these cells are not
as effective in regulating blood glucose levels.
A wide array of xenobiotics and pharmaceuticals impact developmental GSH
profiles, and, consequently Nrf2. Nrf2 is highly pleiotropic, with many functions in
biological processes like inflammation, lipid and xenobiotic metabolism and DNA
repair, in addition to the central role it plays in cancer [166-168, 171]. This
underscores the need to better characterize the functions of Nrf2 during
development. Major redox disruptions during development that manifest as overt
teratogenic effects have been well-studied, with examples like thalidomide having
resulted in strong regulatory outcomes [90, 95, 142]. However, disruptions in
developmental Nrf2a signaling that manifest as subtle changes, as demonstrated in
this study, are easily overlooked until disease outcomes. These subtle changes in
pancreatic morphology likely predispose an individual to develop metabolic disease
later in life. Indeed, in humans, toxicant exposure has been closely associated with
increased rates of metabolic disorders and diabetes by multiple epidemiological
studies [185]. Moreover, we find that there are critical windows of susceptibility to
redox disruptions for the endocrine pancreas. With the daily body burden of
exogenous chemicals increasing, it is critical to better delineate these windows, and,
identify molecular targets like Nrf2a that physicians could potentially use to
monitor health outcomes in exposed and vulnerable populations.
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Figure 3.1. β-cell cluster area is impacted by redox modulation at critical
windows of exposure. (A) Schematic of zebrafish pancreatic development and our
exposure paradigm. [pdx1 – transcription factor in pancreatic progenitor cells;
glucagon – hormone secreted by α-cells; insulin – hormone secreted by β-cells; ptf1a
– transcription factor present in exocrine pancreas] (B) β-cell cluster area in
Tg(insa:eGFP) zebrafish at 96 hpf following exposure to the stated pro- or
antioxidant at 24 hpf (n=30 fish). Below, classification of aberrant islet
morphologies. (C) β-cell cluster area at 96 hpf following exposure to the stated proor antioxidant at 48 hpf (n=37 fish). Below, classification of aberrant islet
morphologies. (D) β-cell cluster area at 96 hpf following exposure to the stated proor antioxidant at 72 hpf (n=34 fish). Below, classification of aberrant islet
morphologies. Different letters represent significant differences from the control.
*p<0.05 as determined by a ONE-WAY ANOVA followed by a Fisher’s LSD Post-Hoc
Test.
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Figure 3.2. Endocrine pancreas has lower antioxidant defenses. (A) Schematic
of all the Nr2a redox modulators used in this study. (B) Nrf2a expression in
pancreatic head and neck of 96 hpf zebrafish embryos (n=23 fish). (C) Protein
glutathionylation in pancreata of 96 hpf zebrafish embryos (n=13 fish). Solid lines
denote exocrine pancreas, dashed lines denote endocrine pancreas. (D)
Quantification of the graded histology patterns. *p<0.05 as determined by a ChiSquare test.
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Figure 3.3. Pancreatic Nrf2a expression and protein glutathionylation
patterns in response to tBOOH exposure. (A) Exposure paradigm (B) Potential
mechanism for tBOOH mediated Nrf2a and protein glutathionylation changes (C)
Nrf2a and protein glutathionylation patterns in pancreata of fish exposed to stated
treatments. Solid lines denote exocrine pancreas, dashed lines denote endocrine
pancreas. Scale bars represent 20 μm. (D) Quantification of the graded histology
patterns. *p<0.05 as determined by a Chi-Square test. Grayscale split channel images
are provided in supplementary information.
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Figure 3.4. Pancreatic Nrf2a expression and protein glutathionylation
patterns in response to tBHQ exposure in Nrf2a wildtype embryos. (A) Nrf2a
and protein glutathionylation patterns in pancreata of fish exposed to 1 μM tBHQ for
6 hours. Solid lines denote exocrine pancreas, dashed lines denote endocrine
pancreas. Scale bars represent 20 μm. (B) Quantification of the graded histology
patterns. *p<0.05 as determined by a Chi-Square test. Grayscale split channel images
are provided in supplementary information.
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Figure 3.5. Pancreatic Nrf2a expression and protein glutathionylation
patterns in response to SFN exposure in Nrf2a wildtype embryos. (A) Nrf2a and
protein glutathionylation patterns in pancreata of fish exposed to 20 μM SFN for 24
hours. Solid lines denote exocrine pancreas, dashed lines denote endocrine
pancreas. Scale bars represent 20 μm. (B) Quantification of the graded histology
patterns. *p<0.05 as determined by a Chi-Square test. Grayscale split channel images
are provided in supplementary information.
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Figure 3.6. Nrf2a is essential for redox dependent disruption of β-cell
morphology. Nrf2a wt/wt or Nrf2a m/m fish exposed to water (n=70 fish), 77.6 μM
tBOOH (n=32 fish) or 776 μM tBOOH (n=35 fish) for 10 minutes at 48 hpf and their
length (A), β-cell cluster area (B) and incidence of hypomorphic islets (cutoff
represented by dashed line) (C) were measured at 96 hpf. Different letters indicate
significantly different means across indicated group. p<0.05 compared to respective
control as determined by a 1-way ANOVA followed by a Tukey-Kramer post-hoc.
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Figure 3.7: α-cell cluster area of zebrafish embryos presented in Fig. 3.1
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Figure 3.8: Pancreatic Nrf2a expression and protein glutathionylation patterns in
response to tBOOH exposure. Pancreatic β-cells of zebrafish embryos exposed to
77.6 μM tBOOH 1 hour (A) or 2 hours (B) post tBOOH exposure. (C) Exposure
paradigm.
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Figure 3.9: Pancreatic Nrf2a expression in response to tBOOH exposure. Grayscale
split channel images from composites presented in Fig. 3.3. Genotypes, channels and
treatments specified in image. All scale bars represent 20 μm. Solid lines denote
exocrine pancreas, dashed lines represent endocrine pancreas.
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Figure 3.10: Pancreatic protein gluathionylation patterns in response to tBOOH
exposure. Grayscale split channel images from composites presented in Fig. 3.3.
Genotypes, channels and treatments specified in image. All scale bars represent 20
μm. Solid lines denote exocrine pancreas, dashed lines represent endocrine
pancreas.
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Figure 3.11: Pancreatic Nrf2a patterns in response to tBHQ and SFN exposure.
Grayscale split channel images from composites presented in Figs. 3.4 & 3.5.
Genotypes, channels and treatments specified in image. All scale bars represent 20
μm. Solid lines denote exocrine pancreas, dashed lines represent endocrine
pancreas.
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Figure 3.12: Pancreatic protein glutathionylation in response to tBHQ and SFN
exposure. Grayscale split channel images from composites presented in Figs. 3.4 &
3.5. Genotypes, channels and treatments specified in image. All scale bars represent
20 μm. Solid lines denote exocrine pancreas, dashed lines represent endocrine
pancreas.
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CHAPTER 4

PERFLUOROOCTANESULFONIC ACID (PFOS) EXERTS DIFFERENTIAL TOXICITY
ON PANCREATIC Β-CELLS AND HUMAN EMBRYONIC KIDNEY CELLS

4.1 Abstract
Perfluorooctane sulfonic acid (PFOS) is a persistent organic pollutant historically
found in firefighting foams and consumer products. It is known to induce the
expression of Nuclear Factor Erythroid 2-like 2 (NFE2L2 or Nrf2), the transcription
factor that regulates many cellular antioxidant defense genes across multiple model
systems. In the zebrafish (Danio rerio) embryo, PFOS is also known to deplete
glutathione (GSH), the predominant cellular redox buffer; pancreatic β-cells are a
sensitive target of PFOS toxicity. Using immunohistochemical approaches in the
zebrafish pancreas, we demonstrated aberrant expression of Nrf2a (zebrafish Nrf2
co-ortholog) protein in developing β-cells upon a chronic 3.2 μM PFOS exposure;
these aberrations were rescued by concurrent 100 μM N-AcetylCysteine (NAC)
exposures, which bolster cellular GSH pools. We further interrogated whether PFOS
activates Nrf2 by inducing reactive oxygen species (ROS) or via GSH depletion using
βTC6 (mouse insulinoma) and HEK293T (human embryonic kidney) cell lines. A
DCF assay used to quantify ROS levels revealed no significant induction of ROS
following 24 hour exposures to 1.6, 3.2, 6.4, 16, 32, 64 or 160 μM PFOS in either cell
line, βTC6 cells did demonstrate greater ROS generation upon exposure to 50 μM
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prooxidant tert-Butylhydroperoxide (tBOOH). Experiments with Grx1-cyto-roGFP2,
a genetically encoded biosensor that detects cellular GSH redox potential, showed
no changes in the GSH redox potential. GSH pools in both cell lines were significantly
oxidized by 50 μM tBOOH, HEK293T cells were able to return to homeostasis within
3 hours, GSH pools in βTC6 cells stayed oxidized 24 hours later; tBOOH exposed
βTC6 cells demonstrated a 60% loss in viability compared to a 20% loss seen in
tBOOH exposed HEK293T cells. These results were confirmed by redox HPLC, the
gold-standard method used to measure GSH and GSSG levels in exposed cells; PFOS
exposures did not alter cellular GSH levels as determined by HPLC. We used a
human Nrf2-GFP fusion protein to determine nuclear translocation of Nrf2 following
PFOS exposure. We found a non-linear relationship, with only 6.4 and 64 μM PFOS
inducing Nrf2 translocation at the same time as the Nrf2 activator 100 μM tertButylhydroquinone (tBHQ), however, this experiment needs to be repeated before
inferences can be drawn. Collectively, our data demonstrate that PFOS induces
redox toxicity in vivo, but not in vitro. Given the recent push to move to alternate and
in vitro models of toxicity testing, this work highlights the need to better understand
these model systems before translatable studies can be performed.

4.2 Introduction
Perfluorooctanesulfonic acid (PFOS), an industrial chemical used in
consumer products and firefighting foams, is ubiquitous in marine and terrestrial
animals [187, 188]. PFOS has been shown to be hepatotoxic, nephrotoxic, neurotoxic
and a potential carcinogen across multiple in vitro and in vivo models, however, the
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mechanisms underlying PFOS toxicity remain poorly understood [189]. A persistent
organic pollutant with a tendency to bioaccumulate, PFOS has been detected in
human amniotic fluid, rendering the vulnerable developing embryo susceptible to
PFOS toxicity [190]. The heightened susceptibility of the developing embryo to PFOS
is further evidenced by the fact that human prenatal PFOS exposures are closely
associated with increased rates of metabolic disorders, diabetes and lower birth
weights [191, 192].
Redox dysfunction is increasingly implicated as an underlying cause of PFOS
toxicity across multiple organ systems and models [193-196]. Cellular redox
homeostasis is maintained by a variety of intracellular buffers, the predominant of
these being glutathione (GSH), present in millimolar ranges in cells [20, 161]. During
embryogenesis, spatiotemporal GSH distribution causes organs to develop in
specific redox microenvironments, leading to variations in susceptibility of
developing organ systems to toxicants [76]. Previously, we have shown the
developing pancreas is especially sensitive to GSH modulation upon developmental
PFOS exposures [76]. Moreover, pancreatic morphology is adversely impacted with
developmental PFOS exposures leading to truncated pancreas tails and abnormal
arrangements of pancreatic β-cells in the islets of Langerhans [71, 158]. Here, we
investigated the molecular mechanisms underlying this toxicity, with a specific
focus on the transcription factor Nrf2.
Nuclear Factor Erythroid 2-like 2 (NFE2L2 or Nrf2) is a basic leucine zipper
transcription factor conserved across all vertebrates. Under homeostatic conditions,
a dimer of Kelch like ECH-associated protein 1 (Keap1) stabilizes Nrf2 in the cytosol.
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Keap1 facilitates terminal ubiquitination of Nrf2 by a Cul3 based E3 ligase, allowing
for its proteasomal degradation [27, 28]. Many internal and external stressors
disrupt the ability of Keap1 to form protein-protein interactions, leading to its
dissociation from Nrf2. Upon dissociation, Nrf2 localizes to the nucleus and binds to
various Antioxidant Response Elements (AREs), thereby activating transcription of a
battery of antioxidant genes like glutathione-s-transferase, Heme Oxygenase-1,
various multidrug resistance proteins and glutathione (GSH) synthesis genes,
thereby maintaining redox homeostasis [30-32]. There is also evidence for a
reduction in ubiquitination of Nrf2 upon redox disruptions, causing the existing
Nrf2 to stoichiometrically bind to all the Keap1 present in the cytosol, outcompeting
de novo synthesized Nrf2. This allows de novo synthesized Nrf2 to translocate to the
nucleus, thereby activating the ARE gene battery [26, 197]. Reduced GSH can be
oxidized to glutathione disulfide (GSSG), neutralizing reactive oxygen species (ROS);
this reversible reaction provides the first line of defense against xenobiotic
mediated redox disruptions [3, 5]. Nrf2 regulated genes are known to be
upregulated in PFOS exposed zebrafish embryos [72].
In the zebrafish pancreas, aberrant Nrf2a (human Nrf2 co-orthologue)
expression patterns have been shown to result in disrupted β-cell morphogenesis;
these disruptions can be rescued by bolstering cellular GSH pools, thereby
increasing the redox buffering capacity of the embryo (Chapter 3). Given the
relationship between the GSH Eh (cellular redox potential, determined by the
concentrations of GSH and GSSG) and Nrf2, we hypothesized that PFOS induced GSH
Eh changes lead to Nrf2 activation, resulting in toxic outcomes.
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We interrogated the interaction of GSH Eh and Nrf2 activation upon PFOS
exposures in pancreatic β-cells using zebrafish embryos, human embryonic kidney
cells (HEK293T) and mouse pancreatic β-cells (βTC6). We used in situ fluorescence
immunohistochemistry to study Nrf2a expression patterns in zebrafish embryos,
and a DCF assay, Grx1-roGFP2 and Nrf2 fusion proteins in mammalian cell culture to
better understand the relationship between PFOS induced changes in GSH Eh and
Nrf2 activation. Rapid exogenous development, conserved redox systems and
conserved pancreatic structure make zebrafish embryos an ideal candidate for
studying the developing pancreas. Mammalian cell culture enables mechanistic
studies at a resolution that are currently not possible in a whole embryo. βTC6 cells
provide a model for pancreatic β-cells, for although they are an insulinoma cell line,
they are one of the few β-cell lines available that do not require glutathione
supplementation in the cell culture media. The kidney is a known target of PFOS
toxicity, and, HEK293T cells are not cancerous in origin and therefore have
conserved normal Nrf2 signaling [189, 198].

4.3 Materials and Methods

4.3.1 Chemicals and Reagents
2',7'-dichlorodihydrofluorescein diacetate (DCF; Catalog #D399),
Paraformaldehyde (PFA; Catalog # AAJ19943K2), Phosphate Buffered Saline (PBS;
Catalog #AAJ75889AE), Methanol (Catalog #A412-4), Tween-20 (Catalog #BP337100), and Dimethyl Sulfoxide (DMSO; Catalog #BP231-1) were purchased from
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Fisher Scientific (Pittsburgh, PA, USA). Tert-Butyl hydroperoxide (tBOOH; Catalog
#A13926AP) and N-acetyl-L-cysteine (NAC; Catalog #A1540914) were purchased
from Alfa Aesar (Ward Hill, MA, USA). Vectashield Antifade Mounting Medium with
DAPI (Catalog #H-1200) was purchased from Vector Laboratories (Burlingame, CA,
USA). Chicken Anti-Rabbit IgG AlexaFluor 594 (Catalog # A-21442), AlexaFluor 594
tagged Streptavidin (Catalog # S32356) and Biotinylated Glutathione Ethyl Ester
(BioGEE; Catalog #G36000) were purchased from Invitrogen (Carlsbad, CA, USA).
Media

4.3.2 Fish Husbandry and Embryo Sampling
Tg(insa:eGFP) and Tg(gcga:eGFP) transgenic zebrafish on wild type (AB)
background were used for in vivo observation of the β-cells and α -cells,
respectively. Homozygous wild type (nrf2a+/+) and nrf2afh318/fh318 crossed with
Tg(insa:eGFP) zebrafish embryos on an AB strain background were used to
investigate the Nrf2 pathway in the developing β-cells. All breeding adults were
maintained on an automated Aquaneering (San Diego, CA, USA) system in
accordance with the Guide for the Care and the Use of Laboratory Animals of the
National Institutes of Health and with approval from the University of
Massachusetts Amherst Institutional Animal Care and Use Committee (Animal
Welfare Assurance Number A3551-01). The fish were housed at 28.5 °C on a 14 h
light, 10 h dark cycle, and fed GEMMA Micro 300 (Skretting, Westbrook, ME, USA)
twice daily. Large breeding tanks were setup with approximately 20 adult female
and 10 adult male fish. Embryos were collected 1 h post fertilization, washed and
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screened for fertilization status and staged according to Kimmel et al. [112]. The
embryos were dechorionated at 24 hpf and reared in borosilicate glass scintillation
vials with 1 ml 0.3x Danieau's per embryo.

4.3.3 Cell Culture
HEK293T cells (Catalog #CRL-3216, ATCC, a generous gift from Dr. Daniel
Hebert) were authenticated via STR Profiling services offered by ATCC (Catalog
#135-XV) and cultured in DMEM supplemented with 10% FBS and 1% PenStrep.
βTC6 cells (Catalog #CRL-11506) were purchased from ATCC (Manassas, VA, USA)
and maintained in DMEM cultured with 15% FBS and 1% PenStrep. Both cell lines
were cultured at 37 °C in an incubator with a humidified atmosphere supplanted
with 5% CO2. Multiple splits of all the cell lines were frozen and stored in the vapor
phase of liquid nitrogen, with the passage number never exceeding 30.

4.3.4Plasmid Generation and Stable and Transient Transfections
The cyto Grx1-roGFP2 construct was PCR amplified from pLPCX cyto Grx1roGFP2 (Addgene; Plasmid #64975) using the primers 5’GGCGAATTCATGGCTCAAGAGTTTGTGAACT-3’ and 5’GCATGTCGACTGCCTTACTTGTACAGCTCGTCCA-3’ and subcloned into the BamHI
and SalI sites of pIRESPuro3 (Clontech). HEK293T cells were plated in 6-well plates
at a density of 500,000 cells/well and transfected with 500 ng/well pIRESPuro3
cyto Grx1-roGFP2 using Lipofectamine P3000 (Invitrogen, Catalog #L3000). The
cells were visually screened for GFP fluorescence 48 hours later, the media was
subsequently refreshed to media containing 1 μg/ml puromycin. Cells were cultured
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in this media for 14 days with media containing puromycin refreshed every three
days to obtain stable transfectants. Finally, the cells were sorted using FACS to
obtain single colonies and one clone was selected to ensure genetic homogeneity.
βTC6 cells were transiently transfected in 96-well plates (50 ng plasmid/well) prior
to experiments due to their inability to stably express cyto Grx1-roGFP2 over
multiple passages.

4.3.5 DCF Assay
Cells were plated in 96-well black plates (Fisher Scientific, Catalog #12-56670) at a density of 10,000 cells/well and allowed to reach 85% confluence. The cells
were then exposed to 10 μM DCF for 40 minutes in serum free media, followed by
three PBS washes. The cells were then dosed with 50 μM tert-Butylhydroperoxide
(tBOOH, a peroxide prooxidant), 1.6, 3.2, 6.4, 16, 32, 64 or 160 μM PFOS (Final
DMSO Concentration = 0.1%). DCF fluorescence intensities were read at 15 minutes,
1 hour and 24 hours post dosing. At 25 points in each well, emission intensities at
529 nm following an excitation of 492 nm were measured using a Cytation 3
Imaging Reader (Biotek Instruments, VT, USA). All experiments were done in
phenol-red free media to minimize background fluorescence.

4.3.6 roGFP Assay and MTT Assay
βTC6 cells and stably transfected HEK293T cells were plated in 96-well black
plates (Fisher Scientific, Catalog #12-566-70) at a density of 10,000 cells/well and
allowed to reach 85% confluence. βTC6 cells were transiently transfected 24 hours
prior to dosing. The cells were switched to CO2 equilibrated HEPES buffered DMEM,
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owing to its superior buffering capacity for mammalian cell culture in the absence of
CO2 [199]. A 15-minute baseline was recorded, with a reading every 5 minutes. The
cells were then dosed with 50 μM tBOOH, 1.6, 3.2, 6.4, 16, 32, 64 or 160 μM PFOS
(Final DMSO Concentration = 0.1%). This was followed by a 24 hour time lapse with
a reading recorded every 10 minutes. Emission intensities at 510 nm following
excitations at 405 nm and 488 nm were read; 10 points were measured in per well
using a Cytation 3 Imaging Reader [200]. Following the roGFP Assay, an MTT Assay
(Cayman Chemical, Catalog #NC9799724) was performed to assess cell viability
based on the manufacturer’s specifications.

4.3.7 Nrf2-GFP Translocation Experiments
HEK293T cells were plated in 12-well plates and transiently transfected with
500 μg/well pcDNA3-EGFP-C4-Nrf2 (Addgene Plasmid # 21549) [201]. Stable
transfections were attempted, but the cells did not sustain expression of Nrf2 under
the selection agent puromycin. Puromycin exerts its selective activity by inhibiting
translation in untransfected cells, this does induce a degree of stress on all cells and
could accelerate Nrf2 degradation in exposed cells. The cells were switched to CO2
equilibrated HEPES buffered DMEM 24 hours post transfection and time-lapse
fluorescent microscopy was performed using an EVOS Fl Auto Imaging System (Life
Science Pittsburgh, PA, USA) equipped with GFP and DAPI filters. NucBlue
LiveReady Probes Reagent (Invitrogen; Catalog#R37605) was used as a nuclear
counter stain. Images were taken every ten minutes for 20 hours.
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4.3.8 GSH HPLC
For redox HPLC, cells were cultured to confluence in 6-well plates and dosed
with 0.1% DMSO, 1.6, 3.2, 16 and 32 μM PFOS for 24 hours. The media was removed
and the cells were briefly rinsed in ice-cold PBS. They were collected in 325 μl icecold 10% perchloric acid containing γ-glutamylglutamate as an internal standard.
HPLC was run by the Hansen lab (Brigham Young University) according to
previously defined methods [48, 87].

4.4 Results

4.4.1 PFOS stabilizes Nrf2a in zebrafish endocrine pancreas
Upon chronic developmental exposures to 3.2 μM PFOS, 100% of the Nrf2a
wt/wt embryos displayed aberrant cells expressing Nrf2a the endocrine pancreas
(p<0.05; Fig. 1). However, these cells were not pancreatic β-cells. To investigate if these
were α-cells, we repeated the experiment in Tg(gcga::eGFP) embryos, where the α-cells
express GFP. We found that the Nrf2a positive cells were not α-cells either (p<0.05; Fig.
1). At this developmental stage, the islet has approximately 90-100 cells, and less than
1% of these are ε-cells; we see approximately 5-10 Nrf2a positive cells, indicating they
are likely δ-cells [162, 202]. Co-exposure to a 100 μM NAC protected against changes
in Nrf2a protein expression in the endocrine islet, indicating the sufficiency of GSH
disruption to induce Nrf2a. Nrf2a m/m fish showed no changes in expression of Nrf2a
compared to DMSO controls, implying Nrf2a upregulation is self-regulated at this dose
of PFOS. (p<0.05; Fig. 1).
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4.4.2 PFOS does not induce ROS in cell culture
In cultured HEK293T and βTC6 cells, we saw no changes in ROS levels as
measured by a DCF assay upon PFOS exposure over a 24 hour period (Fig. 2). Both
cell lines demonstrated increased DCF fluorescence across all treatments during this
time period, however, these did not differ significantly from media and DMSO
controls. Notably, βTC6 cells showed greater DCF fluorescence when compared to
HEK293T cells exposed to 50 μM tBOOH (Fig. 2; p<0.05). The lower ROS levels in
βTC6 cells upon exposure to higher doses of PFOS were an artefact of increased cell
detachment at these doses. In cells pre-dosed with 100 μM N-AcetylCysteine (NAC;
bolsters cellular GSH pools) showed an overall decrease in endogenous ROS
production over 24 hours (Fig. 2)

4.4.3 PFOS does not alter GSH Eh in cell culture
To test changes in GSH Eh, we used cyto-Grx1-roGFP2 in HEK293T and βTC6
cells. All doses of PFOS induced no meaningful changes in GSH Eh (Fig. 3). HEK293T
cells had an oxidized GSH pool immediately post a 50 μM tBOOH treatment but
recovered around 2 hours post treatment (Fig. 3; p<0.05). In contrast, βTC6 cells
showed oxidized GSH pools starting 20 minutes post exposure to 50 μM tBOOH, but
unlike HEK293T cells, the GSH pools stayed oxidized 24 hours later (Fig. 3; p<0.05).
We further tested GSH Eh changes using HPLC. βTC6 cells had a 10 mV more
oxidized baseline redox potential when compared to HEK293T cells (Fig. 4; p<0.05).
Concordant with the cyto-Grx1-roGFP2 experiments, 1.6, 3.2, 16 and 32 μM PFOS
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induced no GSH Eh changes in HEK293T cells (Fig. 4). βTC6 cells treated with PFOS
have been submitted for HPLC, we are awaiting results.

4.4.4 tBOOH induces greater cytotoxicity in βTC6 cells
Cell viability was measured using a MTT assay in cells immediately following
the termination of cyto-Grx1-roGFP2 experiments, amounting to a 24 hour long
exposure to each toxicant. Following exposure to 50 μM tBOOH, βTC6 cells showed a
60% decrease in viability, whereas HEK293T cells showed only a 20% decrease in
viability (Fig. 5; p<0.05). βTC6 cells also showed a 20% decrease in viability upon
exposure to 160 μM PFOS, a dose not significantly cytotoxic to HEK293T cells (Fig.
5; p<0.05).

4.4.5 PFOS exposures induce Nrf2 translocation in HEK293T cells
Transiently transfected HEK293T cells were used to assess Nrf2 localization
in live cells. Upon exposure to 50 μM tBOOH, 40% of the cells imaged had Nrf2-GFP
predominantly in the nucleus immediately post exposure (Fig. 6). Exposures to 100
μM tert-Butylhydroquinone (tBHQ; canonical Nrf2 activator), 6.4 μM PFOS and 64
μM PFOS resulted in nuclear localization of Nrf2-GFP in 20%, 25% and 30% of cells
respectively (Fig. 6). Cells exposed to 0.1% DMSO and other doses of PFOS did not
show nuclear accumulation of Nrf2-GFP until 210 minutes post exposure. Worth
noting here, these results are from a single experiment. Due to technical limitations
of our microscope, the number of treatment conditions we could image was
restricted. We have secured IALS LMF Core Discretionary Funds to optimize and
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continue these experiments on the High Content Analyzer available there. These
experiments were also attempted in βTC6 cells, but these cells expressed no visible
Nrf2-GFP upon transfection, potentially due to accelerated Nrf2 degradation.

4.5 Discussion
Despite PFOS manufacturing being phased out of the United States in the
early 2000s, PFOS is still manufactured and used in consumer products imported
into the United States, leading to continued exposures [203, 204]. Moreover, there is
evidence linking human PFOS exposure to increased incidence of diabetes, but there
is little mechanistic understanding of this etiology [191]. Here, we aimed to better
understand this mechanism in the context of redox biology.
The pancreatic β-cell secretes insulin, and in conjunction with other
pancreatic endocrine cell types, regulates blood glucose homeostasis; pancreatic βcell dysfunction is a hallmark of diabetes [157]. β-cells utilize redox signaling both
during proliferation, and, for their function in insulin release [159]. To facilitate this,
adult β-cells are known to possess inherently lower antioxidant defenses [53, 160].
More recently, we showed that developing β-cells also have lower antioxidant
defenses in the form of no Nrf2a protein expression and more oxidized GSH pools
(Chapter 3).
In zebrafish embryos, PFOS induced aberrant expression of Nrf2a in the
endocrine islet, however this was not in insulin secreting β-cells or glucagon
secreting α-cells (Fig. 1). Given that ε-cells make up less than 1% of the islet [202],
and we see a large number of Nrf2a positive cells, these cells are likely
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somatostatin-secreting δ-cells. Somatostatin plays an important role in the
glucoregulatory axis, by inhibiting the secretion of insulin and glucagon, increasing
blood sugar levels. High levels of somatostatin can lead to diabetes [205]. PFOS and
PFOA (perfluorooctanoic acid) are also reported to bind to leptin receptors and
increase blood leptin and insulin levels resulting in a prediabetic phenotype; leptin
negatively regulates somatostatin secretion [206, 207]. Moreover, in sorted
endocrine pancreas cells from healthy and diabetic human donors, β-cells and δcells follow similar Nrf2 expression patterns – healthy donors have negligible Nrf2
expression in both cell types, Nrf2 expression is significantly increased in cells from
diabetic donors [208]. In addition to implications for disrupted endocrine islet
function, PFOS induced pancreatic Nrf2a changes could impact organ
morphogenesis and development (Chapter 3).
We have also previously shown PFOS exposure results in abnormal islet
variants and decreased islet morphology [71]. Notably, co-exposure to a 100 μM
NAC rescued PFOS induced changes in Nrf2a expression, indicating GSH depletion is
sufficient for Nrf2a activation in the pancreas. Given that PFOS disrupts GSH levels
in the zebrafish pancreas [76], and GSH supplementation rescues redox mediated
aberrant pancreatic Nrf2a expression patterns (Chapter 3), this result further
implicates redox signaling as underlying PFOS toxicity in vivo. This result is also
especially promising, given the ubiquitous nature and long half-lives of PFCs
(perfluorinated compounds – the class of compounds PFOS belongs to). Nrf2a
mutant embryos did not show abnormal Nrf2a expression in the islet, indicating the
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existence of a self-reinforcing, positive feedback loop between Nrf2a expression
upon PFOS exposure (Fig. 1).
Despite clear evidence of PFOS disrupting the GSH Eh and Nrf2a expression
patterns in zebrafish embryos [71, 72, 76], our cell culture data showed no changes
in ROS production or GSH Eh upon PFOS exposure in either HEK293T cells or βTC6
cells (Figs. 2-5). However, our data clearly demonstrate the inherent redox
sensitivity of pancreatic β-cells. βTC6 cells start out with a 10 mV more oxidized
GSH Eh, and, have higher ROS production levels upon exposure to the same levels of
tBOOH (Fig. 2; Fig. 5). Moreover, upon exposure to tBOOH, HEK293T cells are able
to recover in a short time and return to homeostasis, but βTC6 cells are unable to
cope with the same stress leading to sustained oxidation of the GSH pools
culminating in cell death (Fig. 3; Fig. 4).
A notable confounder in all cell based studies is the fetal bovine serum (FBS)
used to culture cells. Owing to its biological origins, contents of FBS are inherently
variable with many constituents unknown [209, 210]. In addition to biological
components, serum will contain xenobiotics reflective of exposures experienced by
the animal it is derived from. In cattle, blood levels of perfluorinated compounds
have been well-characterized. Cattle administered a single oral dose of 8 mg/kg
body weight PFOS demonstrated the highest accumulation of PFOS in the blood,
with 947 mg PFOS in total blood volume [211]. Based on the reported weights of the
animals, they would have an approximate blood volume of 18 liters (55 ml blood/kg
b.w.) [212], and this corresponds to a 105 μM PFOS.
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Other studies exploring blood levels of total PFCs in naturally exposed cattle
have also reported the blood as having high body burdens of PFCs; one study found
the biomagnification factor of PFOS was 15 in blood, second only to the liver [213].
Another study investigated cattle raised on a naturally contaminated farm; cattle
were exposed via dietary routes to more relevant levels, each animal ate
approximately 2-3 μg/kg b.w. [214]. Cattle were removed from the contaminated
farm after 28 days of continuous exposure, and allowed to recover, the authors
found that blood levels of PFOS were highly elevated and this was sustained 21 days
after termination of exposures [214]. Blood levels were around 2500 μg/L, equating
to approximately 5 μM PFOS. Worth noting here, these studies explored cattle raised
in USDA approved facilities, the same facilities the highest grade of serum is sourced
from.
For every 1 volume of blood, we obtain approximately 1/3 volume of serum
[215]. FBS is enriched in bovine serum albumin (BSA), and, BSA has been shown to
preferentially bind PFCs including PFOS [216, 217]. Thus, it is not unreasonable to
assume that the majority, if not all, of the PFCs in blood is in the serum fraction. This
would equate to around 15 μM PFOS in FBS (from the previously determined 5 μM
PFOS). Since HEK293T cells are cultured in 10% FBS and βTC6 cells are cultured in
15% FBS, they are effectively exposed to 1.5 μM and 2.25 μM PFOS respectively.
These are likely conservative estimates based on current legislation that limits
levels of PFCs. These cell lines are immortalized and have been continuously
cultured for decades, likely with FBS containing significantly higher levels of PFCs.
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Thus, one potential explanation for the lack of PFOS toxicity might simply be due to
an artificial selection of PFOS resistant cells over years of continuous culture.
The in vitro toxicity of PFOS has been demonstrated by other studies
investigating various endpoints. For instance, PFOS was shown to induce
adipogenesis in murine derived 3T3-L1 preadipocytes [218]. The authors
exhaustively tested doses from 1 nM to 500 μM, they reported a 10% decrease in
viability following a 48 hours exposure to 500 μM PFOS [218]. They found increased
triglyceride content in the cells following a 50 μM PFOS exposure for 3 days; an
increase in mRNA levels was also reported at this timepoint, no changes were
observed following a 1 day, or a 2 day exposure [218]. Another study compared
PFOS and PFOA toxicity in human hepatocarcinoma cells (HEPG2), and found no
significant decreases in cell viability until doses exceeded 200 μM for each PFC, 100
μM PFC induced cytotoxicity, but only following longer 2 day or 3 day exposures
[219]. Studies employing longer exposures to higher doses of PFOS are important to
understand specific effects, but, are not quite as toxicologically relevant. Congruent
with our data, this study also did not find any changes in GSH levels except at the
200 μM dose of PFOS following 48 hours of exposure [219]. Another study
investigating ROS production using DCF upon exposure to a battery of PFCs in
HEPG2 cells also did not find significant ROS production upon PFOS exposures
ranging from 0.4 μM to 2 mM [220]. Thus, it is also entirely possible that ROS
production and GSH depletion are not toxic endpoints defining PFOS toxicity in vitro.
In recent times, great emphasis has been placed on shifting predictive
toxicology models to in vitro systems to minimize animal usage, and, the expense
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and time required for conducting studies. The Tox21 initiative is an excellent
example, with goals explicitly stating the development of suitable cellular models to
replace animal testing [221]. The data presented here demonstrate the importance
of critically assessing cell culturing techniques and strictly defining media
components prior to translating data from these studies to human health. Here, only
PFCs were assessed as potential contaminants in serum used to culture cells, but in
reality, serum would contain myriad compounds reflective of the entire exposome
of the animal. Thus, this presents multiple confounders which need to be extensively
tested and validated.
Collectively, these data provide evidence for the heightened redox sensitivity
of the pancreatic β cell. Moreover, PFOS exposure during embryogenesis induces
aberrant expression of Nrf2a in the endocrine pancreas, mediated by GSH
disruptions; aberrant induction of Nrf2a in the endocrine pancreas during
development can lead to abnormal cell morphologies (Chapter 3). Also, by shifting
the redox balance of cells during development, aberrant Nrf2a activation could alter
cell fate decisions, leading to premature differentiation of cells [11, 12]. Recently, a
study linked exocrine pancreatic cancer with exposure to multiple perfluorinated
compounds including PFOS in humans [222]. In the endocrine pancreas, this could
also lead to reduced reserve antioxidant capacities and a subsequent predisposition
to developing diabetes later in life. More experiments need to be done to better
characterize the molecular mechanisms underlying PFOS toxicity, and its functional
implications.
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Our experiments with Nrf2 translocation indicate that PFOS exposures can
induce Nrf2 translocation, independent of GSH modulation. However, these results
are preliminary, repeating and verifying these effects is an important first step in
understanding PFOS toxicity. Glucose induces ROS production to stimulate insulin
secretion in β-cells, owing to hyperglycemia, diabetic patients have elevated ROS
levels in β-cells [223]. To better understand later-life functional implications of
altered early life redox balance in the β-cells and potentially reduced reserve
antioxidant capacity, Grx1-cytoroGFP2 experiments should be repeated in βTC6
cells under hyperglycemic conditions that mimic a diabetic phenotype. A single run
done with βTC6 cells exposed to all the PFOS concentrations in conjunction with 75
mM glucose did not yield results any different from experiments done without
glucose (data not shown). However, further experiments need to be done to
optimize the dosage of glucose; βTC6 cells are normally cultured in media
containing 25 mM glucose.
The existence of an interplay between changes in GSH Eh and changes in Nrf2
signaling mediating the redox toxicity of PFOS is clear. However, the exact
magnitude of change required in the GSH Eh to disrupt normal Nrf2 signaling
remains to be determined.

4.6 Funding
This work was supported by NIEHS R01ES025748 (ART-L).

110

Figure 4.1: PFOS disrupts Nrf2a signaling in the endocrine pancreas. (A) Nrf2a
protein expression patterns in pancreata of fish exposed to 3.2 μM PFOS from 3 hpf
to 96 hpf. Solid lines denote exocrine pancreas, dashed lines denote endocrine
pancreas. Scale bars represent 20 μm. (B) Quantification of the graded histology
patterns. *p<0.05 as determined by a Chi-Square test. Grayscale split channel images
are provided in supplementary information.
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Figure 4.2: PFOS does not induce ROS in cultured cells. ROS levels as
determined by a DCF assay upon stated exposures in (A) HEK293T cells, (B)
HEK293T cells pretreated with 100 μM NAC, (C) βTC6 cells (D) βTC6 cells
pretreated with 100 μM NAC. *p<0.05, compared to first timepoint within each
treatment group, determined by 1-WAY ANOVA, Tukey-Kramer Posthoc. HEK293T
cells also had significantly lower ROS levels upon NAC pretreatment as determined
by a 2-WAY ANOVA, Tukey-Kramer Posthoc. N= 3 independent experiments; 4
technical replicates within each experiment
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Figure 4.3: PFOS does not oxidize Grx1-cytoroGFP2 in cultured cells. Oxidation
status of Grx1-cytoroGFP2 in (A) HEK293T cells and (B) βTC6 cells following stated
exposures. ***p<0.05, 1-WAY ANOVA, Tukey-Kramer Posthoc. N= 3 independent
experiments; 4 technical replicates within each experiment

113

Figure 4.4: βTC6 cells are more susceptible to redox stress. Cell viability of (A)
HEK293T cells and (B) βTC6 cells following stated exposures as determined by a
MTT assay. *p<0.05, 1-WAY ANOVA, Tukey-Kramer Posthoc. N= 3 independent
experiments; 4 technical replicates within each experiment
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Figure 4. 5: PFOS does not alter GSH Eh as determined by HPLC. (A) GSH Eh of
HEK293T and βTC6 cells computed using the Nernst equation following
determination of intracellular GSH and GSSG concentrations, (B) GSH Eh of HEK293T
cells following stated exposures as determined by HPLC. *p<0.05, 1-WAY ANOVA,
Tukey-Kramer Posthoc. N= 3 independent experiments; 3 technical replicates
within each experiment.
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Figure 4.6: PFOS impacts Nrf2 translocation in HEK293T cells. HEK293T cells
were transiently transfected with GFP-Nrf2, (A) % of cells with nuclear dominant
Nrf2 following stated exposures are presented in graph. (B) Representative images
of a field of view with cells exposed to 32 μM PFOS over time. N= 1 experiment
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CHAPTER 5

SYNTHESIS

5.1 Summary
The goal of this dissertation was to test the central hypothesis that GSH
changes during embryogenesis potentiate Nrf2 leading to adverse developmental
outcomes in an organ specific fashion.
In Chapter 2, monochlorobimane, a GSH specific dye was adapted for the
visualization of GSH in live, developing zebrafish embryos. This work was the first
agnostic in vivo characterization of inherent GSH differences in various organs
during embryogenesis. This chapter answered part of the research question by
demonstrating tightly controlled spatiotemporal GSH distribution during embryonic
development, indicating divergent resiliencies of organs to redox perturbations at
key developmental stages. Upon exposing zebrafish embryos to the toxicants PFOS
and MEHP, glutathione levels changed in a dose-, age- and structure-specific
manner. The developing pancreas was found to be especially sensitive to PFOS
exposure, GSH levels depleted by 50% following exposure, implicating redox
changes as a potential driver of PFOS pancreatotoxicity.
Based on the results of Chapter 2 demonstrating the redox susceptibility of
the developing pancreas to toxicant exposure, Chapter 3 took a closer look at the
developing pancreas. Building upon the temporality of GSH during development,
distinct windows of redox susceptibility governing endocrine pancreatogenesis
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were identified. A fundamental role for Nrf2a signaling in endocrine
pancreatogenesis was uncovered. GSH depletion was found to be sufficient to
disrupt Nrf2a homeostasis and aberrant Nrf2a expression was found to be
necessary for disrupted pancreatogenesis. Results from Chapter 3 demonstrated the
ability of GSH disruptions to aberrantly induce Nrf2a in an organ specific fashion. A
novel technical aspect of this chapter was the visualization of changes in protein
glutathionylation levels in situ in whole zebrafish embryos. We found these changes
to be a potential mechanism underlying Nrf2a mediated disruptions.
Chapter 4 dives deeper in the mechanism, trying to tease apart the
contribution of GSH Eh changes and Nrf2a activation to perfluorinated induced
toxicity. Experiments demonstrated that GSH Eh is not altered in vitro upon PFOS
exposure in the same manner as seen in vivo. However, Nrf2 is still activated, though
more experiments need to be done to confirm this.
This project better characterized changes in the GSH Eh during
embryogenesis, and, how toxicant exposures impact GSH Eh in different organ
systems. It delineates critical windows of developmental susceptibility, with a focus
on the endocrine pancreas. Finally, it pinpoints potential molecular markers that
may underly toxic outcomes of perfluorinated exposures during these critical
windows.

5.2 Discussion
The predominant cellular redox buffer, GSH is present in intracellular
concentrations in the millimolar range. Its biological importance is evident from the
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start of life, with specific, directional GSH concentration changes delineating critical
developmental events. Disrupting GSH levels changes cell fate decisions, adversely
impacting developmental outcomes [14-16]. Though the divergent redox resiliency
of different organs during embryogenesis has been previously hypothesized,
detailed studies into these have been severely constrained by technical limitations
[88, 144].
The GSH staining technique using monochlorobimane presented in Chapter 2
helped overcome this critical data gap, allowing for the first agnostic in vivo
visualization of GSH levels in whole zebrafish embryos. The ability to detect GSH
levels in different organ systems and structures represents a significant
advancement. As described earlier, the embryo is a highly organized collection of
diverse cell types and biological matrices. Visualizing in vivo changes in GSH that
correspond to periods of heightened division or differentiation helps contextualize
the many studies done in cell culture.
The developing embryo was found to have tight spatiotemporal regulation of
GSH during development, different organ systems were enriched or depleted of GSH
at specific developmental stages [76]. This allowed for the prediction the potential
temporal window of redox susceptibility of specific organ systems. Testing the
system using the known toxicants PFOS and MEHP revealed that GSH responses
vary based on the dose of the toxicant, age of the embryo and structure being
studied.
PFOS induced the greatest GSH disruptions in the developing pancreas. The
pancreatotoxicity of PFOS is concordant with previous work demonstrating how
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PFOS disrupts pancreatic β-cell development [71]. Chapter 2 implicates redox
dysfunction as a mechanism underlying this pancreatoxtocity with later
experiments in Chapter 4 demonstrating the ability of GSH to rescue this toxicity
providing further evidence for a redox mediated effect. Pancreatic β-cells form the
bulk of the endocrine pancreatic islet with α, 𝛿, ε and PP-cells making up the rest;
collectively the endocrine pancreas regulates glucose homeostasis [157]. Pancreatic
β-cell dysfunction is the predominant underlying cause of metabolic syndrome and
diabetes. Pancreatic β-cells are especially susceptible to redox insults due to their
inherent biology. They are known to employ reactive oxygen species (ROS) during
both their development, and, for their function in glucose stimulated insulin release
[159].
Chapter 3 investigates Nrf2 signaling in the developing pancreas. Nrf2 is the
transcription factor that regulates the cellular antioxidant defense machinery, and
thus, is a logical first step to understanding the mechanism of toxicant induced
redox dysfunction. The near absence of Nrf2a (zebrafish co-ortholog of human Nrf2)
protein in the zebrafish pancreatic islet demonstrated in Chapter 3 substantiates the
multiple studies that have demonstrated lower redox gene expression in the
pancreas. Moreover, the inverse relationship between Nrf2a expression levels and
protein glutathionylation implicates processes downstream of Nrf2a signaling in the
redox modulation of endocrine pancreatogenesis.
By better characterizing the link between GSH modulation, Nrf2a expression
and protein glutathionylation, Chapter 3 illuminates an important pathway that
could be responsible for toxicant induced teratogenesis. Chapter 2 highlighted how
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a ten minute tBOOH treatment in zebrafish embryos aged 48 hpf depleted 50% of
GSH; GSH levels recovered about 30 minutes later. Chapter 3 demonstrates the
sufficiency of that depletion to cause sustained changes in protein expression
patterns. Two days later at 96 hpf, β-cell area was significantly reduced, islet
morphology variants were significantly higher, and, Nrf2a was expressed in
pancreatic β-cells. These changes were rescued by NAC supplementation, which
bolsters cellular GSH pools, evidencing the sufficiency of GSH depletion to induce
changes in Nrf2a expression in β-cells. The redox modulators tBHQ and
sulforaphane, which we are exposed to via dietary sources, also activated Nrf2a in
pancreatic β-cells.
Contextualizing aberrant activation of Nrf2 in endocrine pancreatic cells is
important. In pancreatic β-cells collected from non-diabetic human donors, Nrf2
was found to be largely absent in healthy, functioning β-cells, agreeing with our
findings in zebrafish [224]. Nrf2 expression was increased in β-cells that had
decreased levels of insulin expression and showed the unfolded protein stress
response. Thus, Nrf2 activation was found to be a coping mechanism for β-cells,
resulting in impaired β-cell function. Similar results have been reported in mice
[183, 184]. Chemically activating Nrf2 in pancreatic β-cells from human donors
improved survival of the cells, however, these cells were unable to secrete insulin
when transplanted in diabetic mice, further supporting the inverse relationship
between Nrf2 activation and β-cell function [225].
The lower redox capacity of adult pancreatic β-cells is well-characterized
[159]. However, this is the first demonstration of lowered redox capacity of β-cells
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during organ morphogenesis. Redox active xenobiotics induce sustained changes in
the redox homeostasis of β-cells, potentially altering the reserve capacity of these
cells into adulthood. This work is the first to implicate a mechanism for redox
disruptions during pancreatogenesis as underlying aberrant pancreatic
morphologies.
Furthermore, this work explores the roles played by Nrf2 during
embryogenesis. Nrf2, the pleiotropic transcription factor, has hitherto been studied
largely in the context of cancer, with a focus on characterizing the mutations in Nrf2
that lead to carcinogenicity. Canonical wisdom has held that Nrf2 activation is
beneficial, as it activates cellular antioxidant defenses and protects cells from
various stressors. This dissertation provides evidence for how abnormal activation
of Nrf2 at distinct developmental timepoints has deleterious effects on the
developing pancreas. These data add to our understanding of the temporality of
redox homeostasis during development.
In addition to better understanding the fundamental redox biology of the
developing embryo, a key goal of this thesis is to apply these fundamentals to
characterize how xenobiotics impact organogenesis. Based on the results of Chapter
2 and 3, special emphasis was laid on PFOS and the developing pancreas. To further
understand PFOS induced developmental malformations of the pancreas, Chapter 4
uses a mixed model approach to determine how PFOS impacts Nrf2a protein
expression in the pancreas and dives deeper into the cellular mechanisms
underlying PFOS toxicity. PFOS induces Nrf2a in the developing zebrafish pancreas,
however, not in β-cells or α-cells. Aberrant redox signaling during organogenesis
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can have far reaching consequences, slight shifts in the cellular redox potentials are
sufficient to change cell fates from being proliferative to differentiated [46, 47, 86].
In the context of the pancreatic islet, this is notable given the ability of endocrine
pancreatic cells to transdifferentiate; transdifferentiating cells expressing both αcell and β-cell specific markers, have been reported across multiple mammalian
models, including humans [226-228].
Molecular mechanisms of PFOS toxicity were explored further in mammalian
cell culture, using human embryonic kidney cells (HEK293T) and mouse insulinoma
pancreatic β-cells (βTC6). The kidney is a well-characterized target organ of PFOS
toxicity, and experiments from Chapter 2 along with prior work identified the
pancreas as a sensitive target of PFOS toxicity [71, 76, 189]. Using our exposure
paradigm and doses, we did not find evidence for redox toxicity of PFOS in vitro.
A deeper dive into literature revealed this could potentially be an effect of
existing PFCs in the serum used to culture cells. Blood serum levels of cattle used to
obtain foetal bovine serum were as high as 2500 μg/L, which translate to 1.5 – 2.25
μM PFOS in reconstituted cell culture media [211, 214, 216, 217]. Only PFCs were
assessed in the context of this thesis, but serum concentrations of multiple
xenobiotics merit further investigation. Given the emphasis to move to in vitro
models, this presents a significant confounder and needs to be better characterized
to ensure translatability of in vitro studies.

5.3 Significance
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In an increasingly industrialized world, exposures to industrial chemicals are
on the rise. While overtly toxic chemicals are easily identified and regulated,
chemicals that have subtle effects are overlooked. This problem is magnified when
considering the case of developmental toxicants. Regulations and public health
advisories over well-characterized teratogens like alcohol and thalidomide abound,
but, lesser known toxicants remain understudied. There are minimal to no toxicity
data for 78% of the estimated 75,000 commercial chemicals in use today, in no small
part due to the lack of suitable toxicity testing methods [229]. To better characterize
organ specific effects of toxicants and potential teratogens, significant investments
of time and resources need to be made, with focused research efforts investigating
each organ system independently.
The technique for visualizing GSH changes in live embryos overcomes this,
by enabling the identification of subtle changes in the whole, live embryo. As an
unbiased measure, it helps generate crucial pilot data that can then be used to
inform what systems further studies should focus on. It is an inexpensive technique
which can be applied in simply appointed research labs, and is amenable to high
throughput adaptation. Furthering the aims of the Tox21 initiative, the technique
can be used to screen chemicals, using the data to inform adverse outcome pathway
analyses and regulatory decisions.
The redox environment of the developing embryo is highly dynamic, yet
tightly regulated. Understanding this fundamental redox biology is essential to
further our understanding of cell fate decisions. The embryo is an organized
collection of a very diverse population of cells, biological matrices in eukaryotic
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organisms are also known to have divergent redox potentials [48]. By visualizing
GSH in the whole embryo, this thesis accounts for the multitude of confounding
factors that impact embryonic redox biology. The tight spatiotemporal control of
GSH during development was long hypothesized, but never demonstrated in whole
embryos until this work.
Visualizing Nrf2a expression patterns and protein glutathionylation in situ in
whole embryos was another novel aspect of this thesis. Lowered antioxidant gene
expression has been well-characterized in isolated pancreatic β-cells, however, this
is the first direct evidence of lowered Nrf2a expression and elevated levels of
protein glutathionylation, a marker of oxidized GSH pools. Additionally, this work
shows that GSH depletion is sufficient to induce Nrf2a expression in pancreatic βcells, and, Nrf2a expression and subsequent altered protein glutathionylation is
necessary to induce redox mediated β-cell morphology changes.
Leveraging the predictive power of GSH visualization, the pancreas was
identified as a target organ of PFOS toxicity. PFOS induced aberrant Nrf2a
expression patterns in the endocrine pancreas, which were rescued by bolstering
cellular GSH pools using NAC. At the cellular level, the interrogation of the
relationship between ROS production, changes in GSH Eh, and, Nrf2 activation is
novel. All these aspects have been independently studied, but the link between them
was not explored till this study.
Understanding PFOS toxicity is critical given the emergence of perfluoroalkyl
substances (PFAS), the class of chemicals that PFOS belongs to, as ubiquitous
environmental toxicants. PFAS are recalcitrant, known to bioaccumulate, can cross
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the placental barrier and are present in the blood serum of 97% of the US
population [187, 188, 190, 230]. This thesis provides a potential mechanism for the
pancreatotoxicity, obesogenic and diabetogenic properties of multiple PFAS,
including PFOS [71, 191]. Additionally, these findings indicate the fundamental role
Nrf2 plays in pancreatic development. Given the multitude of xenobiotics that
impact GSH levels and Nrf2, this work points to the utility of Nrf2 as a biomarker of
pancreatic toxicity.
Pancreatic dysfunction most commonly results in diabetes. Diabetes has fast
become a public health crisis in industrialized nations exacerbated by lifestyle and
dietary factors. The annual cost of treating diabetes in the US alone was a staggering
US $327 billion in 2017 [156]. While dietary and lifestyle changes have been well
investigated, the contribution of toxicant exposures remains understudied. These
results indicate that developmental exposures to redox active toxicants can alter the
biology of the developing pancreas, rendering an individual more susceptible to
disease later in life.

5.4 Future Directions
This dissertation characterizes, for the first time, the inherent differences in
GSH levels in different developing organ systems. It demonstrates the lower redox
defenses of β-cells during organ morphogenesis, and how redox active xenobiotic
exposures can cause sustained changes in β-cell redox homeostasis. It lays out the
fundamental redox biology of the developing pancreas. Next, it is important to
explore the functional implications of changes in this fundamental biology.
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To start with, exploring Nrf2a expression and protein glutathionylation
levels under abnormal glycemic conditions mimicking diabetes should be
characterized. Next, isolating and identifying the differentially glutathionylated
proteins in response to redox modulation should be done. By comparing the redox
proteome of pancreatic β-cells post exposure to different toxicants, specific
therapeutic targets and pathways could be identified. Further investigations into the
impacts of these redox changes on β-cell function, and, the persistence of structural
islet variants into adulthood are also important.
Another important question is determination of the specific endocrine cell
type where Nrf2a is being activated in the zebrafish pancreas upon PFOS exposure.
This determination, along with enquiring whether transdifferentiation is occurring
or not are important questions to answer for assessing the mechanistic aspects
underlying pancreatotoxicity of PFOS.
One limitation of this work is that it work tested GSH changes and Nrf2a
activation in independent assays, using multiple model systems. The ideal way to
test these toxicities would be multiplexing the GSH Eh and Nrf2a activation readouts
within the zebrafish pancreatic β-cells. Though technically challenging, this could be
achieved by creating a dual transgenic zebrafish line expressing roGFP and a Nrf2afluorescent fusion protein within the pancreatic β-cells.
Longer term studies should take a closer look at other organ systems that are
impacted by developmental exposures to chemicals. The techniques developed as
part of this thesis can be used to generate organismic level maps of the redox
toxicity of multiple xenobiotics.
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